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Proteins play key roles in biological processes that are highly dependent on their three-
dimensional fold. Given the therapeutic relevance of many proteins, significant research effort 
has pursued the development of unnatural oligomers with protein-like folds. However, as the 
complexity of the target fold pushes beyond secondary structure, the difficulty of recapitulating 
the native protein fold becomes considerably high. There remains an unmet need for methods 
that enable tertiary structure mimicry of proteins by unnatural oligomers. Accessing complex 
protein-like folds on protease-resistant backbones would yield improved therapeutics with high 
target specificity and sustained biological effects in vivo.  
The goal of the current work was to generate design strategies for tertiary protein 
structure mimicry. We selected GB1, a protein that adopts a compact tertiary fold, as a system 
for backbone modification. We systematically replaced residues in the secondary structures of 
GB1 and measured the resulting changes to folding thermodynamics and structure. Combination 
of separate modifications into one protein led to a mutant that showed evidence for tertiary 
folding despite having an ~ 20% unnatural backbone sequence. Furthermore, grafting the 
combined backbone alterations onto a side-chain sequence that encodes for a more stable and 
identical tertiary fold resulted in a significant stabilization of the folded state. The observations 
supported a general design hypothesis that proteins have two mutually orthogonal design 
sequences: 1) backbone and 2) side-chain. 
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The detailed effects of unnatural residues on protein folding thermodynamics were also 
examined and revealed several interesting trends. A series of α→β3 substitutions were 
implemented in GB1. As β3-residues have more flexible backbones than α-residues, we 
investigated rigidification of the backbone through either cyclization or Cα-methylation, which 
somewhat or significantly stabilized the folded state of the protein.  
We studied other types of unnatural residues in the context of a small hairpin peptide. 
γcyc-Residues were found to stabilize the hairpin secondary structure greater than the natural 
backbone. However when applied to GB1, the same strategy was detrimental to folding. 
Optimization of the location of unnatural residues resulted in a restoration of near wild-type 
folded stability.  
Overall the developed strategies should be applicable to larger, more complex protein 
folds. 
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 1 
1.0  INTRODUCTION TO PROTEIN STRUCTURE MIMICRY 
A portion of the background discussed in this chapter was reviewed in: 
Z.E. Reinert, W.S. Horne. "Protein backbone engineering as a strategy to advance 
foldamers toward the frontier of protein-like tertiary structure." Org. Biomol. Chem. 
2014, 12, 8796-8802. 
1.1 BACKBONE MODIFICATION OF PROTEINS 
Proteins, polymers of α-amino acids, perform an incredible number of functions and tasks in 
living systems including catalysis, signal transduction, immune response, and replication of 
genetic material. The vast majority of proteins’ biological roles are determined by their three 
dimensional structure. Many intricate folds have been identified through a variety of high-
resolution methods. Given the wide range of utility and function available to proteins, it is 
interesting to probe how unique polymers of α-amino acids are in their ability to form such 
complex structures. Stated another way, can the sequence-encoded folds of proteins be 
recapitulated on non-native backbones? 
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Figure 1. Selection of unnatural residues that have been explored as replacements for α-residues 
(yellow) in folded proteins. 
 
 
Early work exploring protein backbone alterations was driven in part by two significant 
technological advances in protein synthesis that enabled the construction of large proteins 
bearing noncanonical amino acids (Figure 1): native1 or expressed protein chemical ligation2 and 
heterologous expression of proteins containing unnatural amino acids.3 Native chemical ligation 
(NCL) is based on the reaction of two peptide fragments: one bearing an N-terminal Cys residue 
and the other with a C-terminal thioester (Figure 2). Thioester exchange from attack of the N-
terminal thiol on the thioester carbonyl carbon forms a peptidyl acyl thioester that readily 
undergoes an S,N-acyl shift to yield a native peptide bond. The C-terminal thioester may be 
 3 
generated through SPPS or from biological expression through thiol-mediated intein cleavage as 
in the case of expressed protein ligation.2, 4-5 
 
 
 
Figure 2. Overview of NCL. 
 
 
Expression of proteins coding for unnatural amino acids is made possible through 
nonsense suppression and orthogonal acylated-tRNAs (Figure 3). In short, a stop codon is 
incorporated at a position for an unnatural residue in a protein-coding gene. A tRNA bearing the 
anticodon of the stop codon is charged with the desired unnatural amino acid using an 
engineered aminoacyl-tRNA synthetase. The exogenous synthetase and tRNA must be 
orthogonal to the host cell machinery to efficiently synthesize the target protein. During 
translation of the mRNA transcript, the charged tRNA is recognized by the ribosome and 
ultimately the unnatural protein is produced. This approach has been used for numerous 
applications in proteins, including introduction of biophysical probes,6-7 backbone mutations,3, 8-9 
and reactive and/or fluorescent groups.7, 10-11 Although many noncanonical amino acids can be 
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incorporated using nonsense suppression,12 total chemical synthesis remains the method of 
choice for production of highly backbone-modified proteins. 
 
 
 
Figure 3. Overview of expression of proteins with unnatural amino acids (UAA) using 
engineered aminoacyl tRNA synthetases (aa-RS). 
 
 
Backbone engineering of proteins was first applied to investigate the thermodynamic 
contribution of backbone hydrogen bonds to folding. While known to be energetically important, 
probing individual hydrogen bonds was experimentally challenging due to the need for methods 
that minimally disrupted the folded structure. One solution is to replace an α-amino acid in a 
protein with the α-hydroxy acid analogue. This has the effect of exchanging the amide N-H for 
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an oxygen, which cannot act as a H-bond donor, and weakens the neighboring carbonyl oxygen’s 
ability to act as an acceptor (Figure 4).13 
 
 
 
Figure 4. Summary of main consequences of amide to ester substitution in proteins. 
 
 
Enabled by the aforementioned technologies, an isolated amide to ester substitution was 
initially performed in turkey ovomucoid third domain (OMTKY3) via total chemical synthesis.14 
OMTKY3 is known to inhibit serine proteases and is recognized by chymotrypsin at Leu18 
primarily through hydrogen bonds (Figure 5). When the amide of Leu18 in OMTKY3 was 
replaced with an ester, the resulting depsipeptide had reduced affinity for the protease. The 
thermodynamic contribution of the replaced hydrogen bond towards binding was found to be 
~1.5 kcal/mol. Several other seminal studies have since added to the estimated folding energy 
values for backbone hydrogen bonds in a variety of contexts.14-19 These efforts have revealed that 
hydrogen bonds in hydrophobic environments contribute the greatest free energy to protein 
folding. 
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Figure 5. Close-up of amide in OMTKY3 (yellow, PDB 1CHO)14 that was replaced with an ester 
via total chemical synthesis. Purple structure is chymotrypsin with active site serine residues shown. 
Dotted lines indicate polar contacts necessary for recognition of OMTKY3 inhibitor. 
 
 
Another isosteric replacement for amides is substitution of the carbonyl oxygen for 
sulfur. Similar to esters, thioamides have been employed to provide information on the strength 
of hydrogen bonds in protein-protein interactions.20 The electronic properties of thioamides also 
enable them to act as minimalistic quenchers for both natural21 and synthetic22 fluorescent 
moieties in proteins (Figure 6). This feature has been applied to study the folding mechanisms of 
proteins known to aggregate in neurological disorders.23-24 In addition, the sulfur atom enhances 
the ability of thioamides relative to amides to participate in carbonyl-based stabilizing orbital 
interactions in proteins.25 
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Figure 6. Thioamides can quench intrinsic fluorophores in proteins and provide a reliable readout 
of distance between the fluorescent donor and the acceptor thioamide. Graph on the right shows folded 
structure of Villin Hp35 (left) as a function of temperature monitored by circular dichorism 
measurements. The measured distance between the donor Cnf35 and acceptor thioleucine (Leu’) correlated 
well with conformation of the protein. Figure used with permission from reference 22. Copyright 2010 
American Chemical Society. 
 
 
Proteins in nature are almost exclusively composed of L-α-amino acids, however, 
synthetic peptides are not subject to this limitation. Enantiomers of proteins constructed from 
entirely D-amino acids have been reported.26-28 Intuitively from first principles, D-proteins were 
found to adopt mirror-image folds and, in the case of enzymes, mirror image substrate 
specificity. Aside from providing support for fundamental paradigms of chirality, D-proteins 
have found use in the crystallization of proteins (Figure 7).29-30 Briefly, because proteins are 
intrinsically chiral, they can only crystallize in 65 unique space groups. Racemic protein 
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mixtures, on the other hand, can crystallize in a larger number of achiral space groups that are 
predicted to be much more favorable to typical protein conformations.31 Several high-resolution 
structures of proteins that had been previously elusive or refractory towards standard 
crystallization techniques have been obtained using this method.32-33 
 
 
 
Figure 7. The crystal structure of racemic plectasin (PDB: 3E7R).34 
 
 
The above work largely focused on modification of amides to explore the role of 
hydrogen bonds in protein folding. Other researchers have turned to replacing α-amino acids in 
proteins as a means of improving upon folding and/or function of natural protein scaffolds. A 
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well-known class of amino acids for stabilizing helical secondary structure is Cα-methyl-α-
residues.35-36 Methylation of Cα significantly reduces the backbone conformational freedom 
resulting in an increased preference for helical folds. Aminoisobutyric acid (Aib) is a naturally 
occurring Cα-methyl amino acid that was one of the first noncanonical amino acids to be 
incorporated in a protein through heterologous expression.3 Prior work modified the backbone of 
a flexible flap region of HIV-1 protease with Aib.37 The modified enzyme served as tool to 
obtain structural and kinetic insights into the catalytic mechanism. In a separate study, a series of 
Ala→Aib mutations were performed in a helix-forming subdomain of thermolysin (Figure 8).36 
An increase in folded stability relative to the wild-type protein was observed in all but one Aib 
substitution. Replacement of a flexible residue near the termini of the helix of thermolysin with 
Aib was unfavorable towards folding, which was attributed to a decrease in the entropy of the 
folded state. 
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Figure 8. Structure of thermolysin C-terminal subdomain (PDB 1TRL).36 Alanine residues that 
were systematically replaced with Aib are colored green in both monomers of the dimeric protein. Stick 
models of Ala-residues are shown only in one monomer for clarity. 
 
 
Similar to Cα-methylation, alkylation of the amide nitrogen has been explored as a 
protein backbone modification. N-methyl analogues of α-amino acids are naturally occurring in 
cyclic peptides derived from microbes.38 Methylation of the backbone nitrogen in proteins 
removes a hydrogen bond donor, a feature that has found utility in studying multimeric proteins. 
Interleukin-8 is a secreted protein known to self-associate primarily through a β-sheet formed 
from two strands of each monomer.39 N-methyl residues were used to disrupt this interface by 
blocking an interstrand backbone hydrogen bond (Figure 9).40 Interestingly, the resulting 
monomeric interleukin had biological activity identical to that of the wild-type. In addition to 
methyl groups, entire side-chains have been placed onto the amide nitrogen. Referred to as α-
 11 
peptoids, these N-alkyl glycine derivatives have an achiral backbone.41-42 Bulky chiral side-
chains can be installed to promote right-handed helix formation.41, 43 One notable property of 
peptoids is that they readily cross cellular membranes, making them excellent alternatives to 
natural peptides for studying intracellular protein-ligand interactions (Figure 10).42, 44-47 
 
 
 
Figure 9. Schematic depicting how N-methyl substitution removes a backbone hydrogen bond 
donor.  
 
 
Insertion of a methylene unit into the backbone of an α-amino acid generates a β-amino 
acid, and oligomers of β-amino acids are known as β-peptides. β-Peptides can adopt a diverse 
array of helical folds in solution beyond those seen with natural sequences.48-49 Given their 
similarity to α-peptides, entire secondary structures of natural proteins have been replaced with 
β-analogues.50-51 In one example, the backbone of a helix from interleukin-8 was replaced by a β-
peptide bearing the same side-chains using expressed protein ligation.50 The hybrid α/β-oligomer 
displayed diminished biological activity compared to the wild-type protein.  
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Figure 10. Crystal structure of a synthetic peptide (yellow) containing a peptoid (pink) residue 
bound to the SH3 domain of Sem5 (gray surface) (PDB 2SEM).46 The cartoon highlights the peptoid 
residue in the sequence. 
 
 
Moving away from methylated analogues of α-amino acids, other exotic functional 
groups have been explored in the context of proteins. 1,2,3-triazoles, which have similar dipole 
moments as amides,52 have been incorporated in a tetrameric α-helical coiled-coil peptide 
(Figure 11).53 The heterocycle-containing mutant retained the fold of the native peptide despite 
four central α→triazole substitutions. The role of cis/trans amide isomerization in protein folding 
has also been explored by triazoles. A prolinyl amide in ribonuclease A was replaced with one of 
two regioisomers of a 1,2,3-triazole. The 1,5-disubstituted triazole was found to be superior to 
the 1,4-disubstituted triazole at mimicking the native cis amide.54 Other unnatural linkages used 
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to explore cis/trans isomerization include substituted alkenes,55-56 however, the large difference 
in polarity and size between an amide and an alkene destabilized the protein fold considerably. 
 
 
 
Figure 11. Crystal structure of an analogue of a tetrameric coiled-coil protein bearing 1,2,3-
traizoles (PDB 1UF9).53 Box shows a zoom of a hydrogen bond between a backbone amide and a triazole 
nitrogen. 
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1.2 HIGHER ORDER STRUCTURAL MIMICRY 
The aforementioned literature describes attempts to understand and improve upon the folding 
and function of natural proteins. In all examples, a very small subset of the total residues in a 
protein were modified. These studies are pivotal and reveal new insights into protein folding. 
They also raise the interesting possibility of significantly modifying the protein backbone. 
Increasing the ratio of modified:natural residues to a critical threshold results in a highly-
unnatural oligomer that may exhibit folding behavior akin to the native sequence. 
Fundamentally, expanding the diversity of both chemical and structural motifs beyond that found 
in nature showcases the ability of non-native oligomers to adopt complex folds. From a practical 
standpoint, bioactive polymers that display protein-like folds on non peptidic backbones could 
find use in therapeutic applications. The proteolytic susceptibility of α-peptides often precludes 
their use as drugs. In contrast, unnatural oligomers are not easily recognized by proteases and 
have longer half-lives in serum, prolonging their biological effects.57 
Significant research efforts have explored the design and synthesis of foldamers, non-
native polymers that have strong folding propensities.58 Many common protein secondary 
structures such as helices58-60 and turns61-69 have been displayed by foldamers. However, few 
examples of higher order structural mimicry exist in the literature. In one report, blending α and 
β-residues into a natural oligomeric coiled-coil produced mixed α/β-peptides that retained the 
quaternary structure of the parent protein.70 Extending this methodology to therapeutic peptides, 
the authors replaced several α-residues in a helical sequence derived from HIV gp41 known to 
disrupt virus-cell fusion with β-residues.71 The modified helices did not significantly alter the 
ability of the peptide to block cell-cell fusion except in cases where unnatural residues were 
incorporated near the N-terminus. It was hypothesized that the flexible β-residues were 
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entropically destabilizing towards helix formation. Systematic ridigification of the α/β-backbone 
through the use of cyclic β-residues markedly improved the biological activity of the hybrid 
peptides. In addition, the unnatural backbone oligomers were one to two orders of magnitude 
more resistant to degradation by a promiscuous protease relative to the all α-peptide. 
Homooligomers of β-amino acids can also form helices that self-associate. A de novo 
designed β-dodecamer peptide was found to adopt a homooctameric helix bundle.72 The folding 
of the β-bundle was highly dependent on concentration and required large amounts of oligomer 
to achieve a 90 % folded population. Motivated by this nonideal folding equilibrium, the authors 
computationally designed a variant of the β-peptide and linked two separate peptide chains 
together.73 The second generation oligomer assembled into a tetramer with a higher affinity for 
self-association. Later revisions to the sequence produced a β-oligomer with mild esterase 
activity (Figure 12).74 
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Figure 12. Structure of β-peptide bundle that catalyzes hydrolysis of an aromatic ester substrate. 
Figure used with permission from reference 74. Copyright 2014 American Chemical Society. 
 
 
Helix-turn-helix motifs have been recreated on unnatural backbones bearing β-residues.75 
as well as α-peptoids.76 In the latter case, de novo peptoid sequences that code for small 
covalently linked helices were substituted with imidazole and thiol side-chains resembling those 
of histidine and cysteine residues. In natural proteins, these functional groups can coordinate 
metal ions such as zinc. Using FRET, it was shown that the peptoid helix bundle had a more 
compact fold in the presence of zinc, supporting the design hypothesis (Figure 13). 
 
 
 17 
 
Figure 13. Cartoon of zinc-dependent helix bundle fold of α-peptoid oligomer previously 
reported.76 Stars indicated fluorophores that participated in FRET only when in close proximity. Metal 
binding side-chains of the peptoid helix bound zinc and stabilized bundle formation. 
 
 
Quaternary assemblies of helices have been explored on unnatural backbones. Recently, 
it was shown that urea-based polymers could fold and self-assemble into either helical bundles or 
channel-like structures in water.77 These dodecamers of urea-based residues were synthesized 
using solid-phase methods and bore proteinaceous side-chains. Fine control of folding was 
achieved through changes in the primary sequence. Near atomic resolution crystal structures 
provided detailed insights into the relationship between sequence and structure. 
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1.3 GOALS 
The few examples of tertiary structure mimicry underscore the challenge of pushing foldamer 
design beyond secondary structures. Accessing complex protein-like folds on protease resistant 
backbones could yield improved therapeutics with high target specificity and sustained half-lives 
in serum. The goal of the current work is to develop design strategies for protein tertiary 
structure mimicry. As tertiary structure is a combination of multiple secondary structure units, 
methods for loops, helices, sheets, and turns will be developed or improved upon from literature 
precedent. Provided that suitable design rules exist, many intricate higher order folds of proteins 
should be attainable by foldamers. Additionally, the impact of unnatural residues on protein 
folding thermodynamics is poorly understood. Exploring such effects could inform on design 
considerations for backbone modified proteins. The modifications of each secondary unit that are 
most thermodynamically favorable towards folding will be combined into one sequence to 
generate a foldameric derivative of the native protein. Ideally, this highly modified variant would 
possess a fold identical to that of the wild-type on a heterogeneous backbone oligomer. 
Underlying our design strategy is the hypothesis that every protein has two orthogonal 
aspects: 1) side-chain and 2) backbone sequences. Alterations to one sequence would have 
identical effects towards folding on either a natural or unnatural backbone, provided that both 
oligomers maintain the same fold. Traditionally changes to proteins have focused largely on 
side-chain modifications due to technological limitations for longer sequences. Given the 
aforementioned improved methodologies for the synthesis of highly unnatural analogues of 
proteins, we envision that modulation of side-chain and backbone sequences in tandem could 
produce biomimetics with favorable properties. As an example, if backbone modification 
decreased the stability of the folded state, side-chain mutations may be implemented to 
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compensate for the loss of folding free energy. This dual-sequence design strategy should enable 
the design of oligomers with highly unnatural backbones that maintain the same three 
dimensional structure as the native protein. 
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2.0  DESIGN OF FOLDAMERS WITH PROTEIN-LIKE FOLDING BEHAVIOR 
The results in this chapter have been published in: 
1. Z.E. Reinert, E.D. Musselman, A.H. Elcock, W.S. Horne. "A PEG-based oligomer as a 
backbone replacement for surface-exposed loops in a protein tertiary structure." 
ChemBioChem. 2012, 13, 1107-111. 
2. Z.E. Reinert, G.A. Lengyel, W.S. Horne. "Protein-like tertiary folding behavior from 
heterogeneous backbones." Journal of the American Chemical Society. 2013, 135, 12528-
12531. 
 
The crystallography data collection and structure refinement were performed by W. Seth 
Horne. Molecular dynamics simulations were performed by Eli Musselman and Adrian Elcock 
(University of Iowa). 
 
From Chapter 1, it is clear that mimicry of protein tertiary structure has not been widely explored 
despite the promise of significant fundamental and practical applications. We hypothesized that 
if suitable guidelines existed, a target protein of interest could be used a blueprint for the design 
of a foldameric derivative that would both retain the biological function of the native protein and 
be highly resistant to proteolytic degradation. We therefore set out to develop strategies for 
modifying the backbone of proteins with higher order structure.  
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2.1 MODEL SYSTEM GB1 BACKGROUND 
We wanted to identify a model protein that could serve as a platform for examining various 
design strategies in the context of a tertiary structure. The Immunoglobulin binding domain 1 of 
protein G from Streptococcus (GB1, Figure 14) was selected as a model system for several 
reasons: 1) the entire protein can be synthesized using solid-phase peptide synthesis (SPPS), 2) 
the structure of GB1 has been well characterized by both high-resolution X-ray78 and NMR79 
methods, 3) GB1 folds into a compact tertiary structure that includes every common secondary 
structure (loops, helix, sheet, turns), and 4) it has been previously shown that GB1 is tolerant of 
both backbone and side-chain modifications.80-84 While the tertiary fold of GB1 is relatively 
simple compared to the folds of many larger proteins, it is at the frontier of complexity for 
foldamer targets. We hypothesized that design strategies developed for GB1 would be applicable 
to more complex proteins. 
 
 
 
Figure 14. Structure of GB1 (PDB 2QMT). 
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2.2 SECONDARY STRUCTURE BACKBONE MODIFICATIONS 
2.2.1 Loops 
We first examined loop alteration in GB1 as loops are relatively unstructured regions of proteins 
and would be expected to be most tolerant of backbone modifications. Given this feature of 
loops, we hypothesized that enhancing the conformational freedom beyond what is possible in 
natural backbones may be well accommodated. Segments based on poly (ethylene) glycol (PEG) 
linkers were investigated as replacements for the loops of GB1. PEG is a water-soluble polymer 
that is often used as a spacer to link proteins to fluorophores or other chemical entities including 
nanoparticles.85 PEGylation, the attachment of PEG to the side-chains of residues, has been 
shown to improve physiological stability of proteins;86-87 this has led to several FDA-approved 
drugs based on PEG-modified proteins.88 Few studies have explored PEG as a backbone 
replacement. Prior work found that certain ethylene glycol analogues of a natural 10-residue 
peptide can be effectively recognized by a thioesterase enzyme that is involved in cyclization of 
the antibiotic tyrocidine A.89 The most active PEG-based substrates for the thioesterase were 
those that did not replace residues crucial to cyclization. In another study, a PEG-based oligomer 
served as a dipeptide replacement in 20-residue conotoxins stabilized by three disulfide 
bridges.90 The resulting hybrid peptides displayed improved analgesic properties in vivo.  
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We envisioned that the enhanced conformational freedom of PEG-based loops could 
serve as a chemical tool to locally enhance backbone dynamics. There are two loops in GB1 (1) 
and each is approximately three residues in length. We thus selected a PEG-derived amino acid 
(X) that had the same number of backbone atoms as a tripeptide (Figure 15). We synthesized 
three mutants of GB1 where either the N-terminal (2), C-terminal (3), or both loops (4) were 
replaced with X.91 
 
 
 
Figure 15. Secondary structure of GB1 and sequences of wild-type 1 and PEG mutants 2-4. 
 
 
Circular dichroism (CD) spectroscopy can provide information about the secondary 
structures present in a protein or peptide in solution.92 Strong minima at 208 nm and 222 nm are 
characteristic of α-helices whereas β-sheets will often show a single minimum at 215 nm. CD 
scans were performed on 40 µM protein samples in 20 mM phosphate buffer pH 7 at 4 ºC 
(Figure 16). The CD spectrum of 1 agreed with previously reported scans of wild-type GB1 from 
bacterial expression.93 The single PEG mutants 2 and 3 both showed CD spectra similar to that 
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of protein 1 in both shape and magnitude. Mutant 4 had a slightly reduced molar ellipticity at 220 
nm suggesting a less native-like fold. 
 
 
 
Figure 16. CD scans at 4 °C and thermal melts of 40 µM proteins 1-4 in 20 mM phosphate 
buffered water pH 7. 
 
 
CD thermal melts can provide thermodynamic information on protein folding equilibria. 
A strong characteristic signal of the protein from the CD spectrum is monitored as the 
temperature of the solution is increased to unfold the protein. The resulting unfolding curve may 
be fit to obtain the melting temperature of the protein (Tm), defined as the midpoint of the 
unfolding transition. Thermal denaturation of proteins 1-4 revealed highly cooperative and two-
state unfolding transitions evidenced by the sigmoidal shape of the melting transition (Figure 
16). Such cooperative folding behavior is a characteristic of well-folded tertiary structures in 
general94 and specifically GB195. Thermal stabilities of mutants 2 and 3 were less than that of 
wild-type 1 with an observed ΔTm of ~18 ºC (Table 1). ΔTm can be related to ΔΔGfold, the 
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difference relative to wild-type in the change of free energy of folding (Equation 2.1, see 
experimental).96-97 The ΔΔGfold values for each mutant show that each residue X substitution 
destabilized the protein by ~3 kcal/mol. Mutant 4 showed a ΔΔGfold (~8 kcal/mol) greater than 
what would be predicted from the additive loss of stability based on data obtained for single PEG 
mutants (~ 6 kcal/mol). This result suggested synergistic destabilization of the α-helix by the 
adjacent PEG segments. 
 
 
Table 1. Thermodynamics of Folding for WT GB1 and PEG Mutants as Measured by CD.  
Sequence Tm  (°C) 
ΔHfold  
(kcal/mol) 
ΔTm  
(°C)a 
ΔΔGfold 
(kcal/mol)a 
1 81.4 ± 0.1 -58.4 ± 195 - - 
2 64.7 ± 0.1 - -16.7 2.8 ± 0.1 
3 61.6 ± 0.1 - -19.8 3.3 ± 0.1 
4 32.4 ± 0.2 - -49.8 8.1 ± 0.2 
a. Relative to 1. 
 
 
Prior work has shown that various point mutations in GB1 can lead to changes in 
oligomerization state, including formation of domain-swapped dimers and tetramers.80 We 
performed Gel Permeation Chromatography (GPC) experiments to probe for non-native 
oligomerization states in mutants 2-4. In a GPC experiment, proteins are separated on the basis 
of their three dimensional size under non-denaturing conditions with larger proteins eluting 
earlier than smaller peptides. GPC chromatograms (Figure 17) for 40 µM samples of proteins 1-4 
in phosphate solution pH 7 had identical retention volumes, supporting a monomeric fold. 
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Figure 17. GPC chromatograms of 40 µM proteins 1-4 in 150 mM sodium chloride, 20 mM 
phosphate, pH 7 . GPC was performed on a Superdex-75 column. 
 
 
The strength of protein-protein binding interactions depend critically on the folded 
structure of the protein. Protein G binds to immunoglobulin G (IgG) as a means of coating the 
bacterium with host antibodies to evade the host’s immune system. Each domain of protein G, 
including GB1, is capable of binding IgG antibodies at the Fc or Fab region.98-99 We reasoned that 
the strength of IgG binding affinity should be indicative of how well each mutant’s folded 
structure matched that of the wild-type. Enzyme Linked Immunosorbent Assay (ELISA) 
experiments were performed for proteins 1-4 to compare binding affinities for IgG conjugated to 
horseradish peroxidase (HRP) (Figure 18). Varying concentrations of the GB1 mutants were 
incubated with a fixed concentration of IgG/horseradish peroxidase (HRP) conjugates in 
microtiter plates coated with protein G. The plates were washed and developed with 
tetramethylbenzidine (TMB) and 1 M HCl to obtain absorbance of oxidized TMB, indicative of 
the amount of IgG bound to the wells. 
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Figure 18. Competition ELISA and IC50 values for proteins 1-4. 
 
 
Mutant 2 bound IgG with an affinity indistinguishable from wild-type 1 suggesting 
similarly folded structures. Conversely, mutants 3 and 4 did not show a measureable affinity for 
IgG. A crystal structure of the homologous protein GB2 bound to the Fc domain of IgG shows 
direct contacts between the C-terminal loop and Asn434 of the receptor99 (Figure 19). 
Furthermore, an 11-residue peptide corresponding to this domain has been shown to effectively 
compete with protein G among other full-length proteins for binding to IgG, albeit weakly.100 
Based on these precedents, it is not surprising that modification of the C-terminal loop resulted in 
loss of IgG affinity. Thus, loss of binding affinity of 3 and 4 to IgG does not imply a significant 
difference in folded structure from proteins 1 and 2. 
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Figure 19. The crystal structure of GB2 (yellow; C-terminal loop colored magenta) bound to Fc 
domain of IgG (gray surface) (PDB: 1FCC).99 
 
 
We sought to obtain high-resolution structures of mutants 2-4 but were unable to 
crystallize the proteins in numerous buffers. To obtain data bearing on folded structure in the 
modified backbones, our collaborators (Eli Musselman and Adrian Elcock, University of Iowa) 
performed all-atom molecular dynamics (MD) simulations based on a crystal structure of the 
wild-type.78 Each simulation lasted 1 µs in explicit solvent and was performed using standard 
techniques (see experimental). All proteins remained folded during the simulation (Figure 20). 
Both single-PEG mutants 2 and 3 retained folds similar to that of the wild-type structure with 
RMSD values of ~1-2 Å for backbone atoms relative to the initial structure, suggesting 2 and 3 
have similar folded structures to 1 which agrees with the CD data and supports the presence of a 
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native-like tertiary fold. Double-PEG mutant 4 displayed partial unfolding of the β-sheet and 
unwinding of the α-helix, consistent with the conclusions from CD scan and thermal melt data.  
 
 
 
Figure 20. MD simulations of proteins 1-4. A-D) Snapshots from MD simulations of proteins A) 
1, B) 2, C) 3 and D) 4 with RMSD plots for backbone atoms. E-H) Close-up views of the PEG segments 
in proteins E) 2, F) 3, and G-H) 4 (G and H depict N-terminal and C-terminal loops, respectively). Figure 
used with permission from reference 91. Copyright 2012 Wiley. 
 
 
Due to the inherent flexibility of the PEG-substitution, we were interested in the effects 
of PEG on protein backbone dynamics. Additional analyses were performed on the conformation 
of residue X in mutant 2 and the corresponding N-terminal loop in protein 1. Despite differences 
in chemical structure, the overall positions of the backbones of both proteins were not 
significantly different as shown by their similar RMSD plots (Figure 21). Instead, the PEG 
backbone showed much more conformational freedom than the natural backbone as evidenced 
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by the dihedral angles preferences of the loop residues of proteins 1 and 2 (Figure 21). In wild-
type 1, the dihedral angles did not appreciably vary during the simulation, consistent with the 
low RMSD values of the backbone atoms observed. Residue X in mutant 2 exhibited a much 
wider range of bond dihedrals than the natural backbone, although certain angles were preferred. 
The RMSD plots and the dihedral angle conformational preferences together suggest that PEG 
enhances the torsional dynamics of the backbone atoms while retaining the native positions of 
the atoms. PEG-modified backbones could provide a useful tool to probe the role of backbone 
torsional freedom in protein-ligand interactions where recent work suggests that a defined degree 
of disorder can be important in determining protein function.101-102 
 
 31 
 
 32 
 
Figure 21. RMSD plots for the backbone atoms in the N-terminal loop of A) protein 1 and B) 
mutant 2. Analysis of the dynamics of the loop dihedrals in C) protein 1 and D) mutant 2. For each 
dihedral in the residue 19-21 loop (key to angle nomenclature shown in the structure), plots are shown for 
time-dependent rotation about the bond and the frequency distribution of dihedral values over the course 
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of the 1 µs simulation. Dihedrals are plotted either 0° to 360° or -180° to 180° for clarity. Figure used 
with permission from reference 91. Copyright 2012 Wiley. 
 
 
While PEG-derived backbones were tolerated in the loops of GB1, the thermodynamic 
penalty towards folding was significant (~ 4 kcal/mol/loop). Given our overarching goal of 
combining several secondary structure modifications in one sequence, we turned towards more 
conservative loop replacement strategies. We examined β3-residues (Figure 22) as an alternative 
to PEG for loop replacement. β3-Residues retain the side-chain of the native sequence and have 
greater backbone conformational freedom relative to α-residues by virtue of an additional 
methylene unit. We hypothesized that replacing one residue in each loop with the corresponding 
β3-residue would minimally destabilize the overall protein fold.  
 
 
 
Figure 22. Secondary structure of GB1 and sequence of mutant 5. β3-residues are highlighted 
blue and bolded. R is the side-chain group of the corresponding α-residue. 
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β3-Residues were incorporated into the loops of GB1 (Figure 22). The final residue of 
each loop was replaced with a corresponding β3-residue to generate mutant 5. Mutant 5 showed 
an almost identical CD scan as that of wild-type 1 (Figure 23). A thermal melt of protein 5 
yielded a Tm of 77.6 ± 0.1 °C and a ΔΔGfold of 0.9 ± 0.1 kcal/mol indicating protein 5 is as stable 
as wild-type 1 within 1 kcal/mol. This small destabilization may arise from the introduction of 
flexible methylene units in the backbone, increasing the entropy of the unfolded state. This 
hypothesis is explored more thoroughly in Chapter 3. The enhanced folded stability of 5 over 
PEG mutants 2-4 confirmed the conservative approach of β3-residue backbone replacement in 
GB1 relative to PEG-derived analogs.  
 
 
 
Figure 23. CD scans at 25 °C and thermal melts of proteins 1 and 5 in 20 mM phosphate buffered 
water pH 7. 
 
 
A crystal structure of 5 (Figure 24) was obtained using the hanging drop vapor diffusion 
method. A small (~ 1 µL) volume of a concentrated (> 10 mg/mL) sample of protein is mixed 
with a small volume of crystallization buffer. The mixture is then suspended over a larger 
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volume solution of the crystallization buffer in a sealed chamber. Vapor diffusion of water from 
the protein droplet into the reservoir decreases solubility and drives crystallization of the protein. 
The crystal was subjected X-ray radiation and diffracted out to 2.00 Å. The diffraction pattern 
was solved by molecular replacement using the published wild-type GB1 crystal structure 
(2QMT). The unit cell of the crystal structure of 5 featured two copies of the mutant protein in 
the asymmetric unit. It is notable that the two chains have slight differences in the N-terminal β-
turn with an RMSD value of 0.377 Å. The overlay of the lowest RMSD copy with the wild-type 
showed a nearly identical tertiary structure, consistent with the CD scan of 5. The β3-residues did 
not alter main chain hydrogen bonds present in the wild-type structure including those of Ala20 
and Glu19 which participate in the adjacent β-strand. Most of the side-chain polar contacts were 
retained from the wild-type structure. Interestingly, replacement of Asp40 with the β3-homologue 
caused the carbonyl oxygen of the β3-residue to participate in a new hydrogen bond with the 
indole NH of Trp43. The side-chain carboxylate also formed a new polar contact with the side-
chain amide of Asn35. Altogether, the structural data suggested that the additional methylene 
units in the backbone of the loops are well-accommodated in GB1 and important tertiary contacts 
in the native structure were maintained in the mutant. 
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Figure 24. A) Protein 5 (yellow) overlaid with wild-type GB1 (purple, PDB: 2QMT). B, C) 
Close ups of C-terminal loop polar contacts (yellow dashed lines) in wild-type GB1 (B) and mutant 5 (C). 
β3-Residues are colored cyan. 
 
 
Both PEG-based and β3-residue substitutions have been applied the loops of GB1. The 
PEG-based residues may be suitable as a tool exploring the role of backbone conformational 
freedom in protein folding. However, the loss of folded stability from this substitution (~4 
kcal/mol for one loop replacement) is too large to be effectively used in concert with strategies 
for sequence-based modification of other secondary structures. β3-Residues, like PEG-derived 
residues, are more flexible than α-amino acids but their incorporation into the loops of GB1 is 
less detrimental to protein folding and should be more suitable to use with other unnatural amino 
acids for wholesale tertiary structure replacement of GB1. 
2.2.2 Helix 
The α-helix is the most common secondary structure element of proteins and present at many 
protein-protein interfaces.103 The vast majority of foldamer research has been aimed at 
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mimicking α-helical folds with both de novo59, 104-105 and sequence-based design approaches.70, 
106 Several classes of unnatural residues have shown strong preferences for forming helices in 
solution including Cα-methyl-residues,35 β-residues,49 γ-residues,107 peptoids,108 and aromatic 
residues.59 Prior studies have shown that α/β3-peptides derived from α-helix-forming sequences 
can fold into α-helices with similar structure to the native α-peptide in aqueous solution70 and 
retain biological function.71, 106, 109  
 
 
 
Figure 25. Sequences of GB1 helix mutants 6 and 7. R is the side-chain group of the 
corresponding α-residue. 
 
 
We designed two GB1 sequences to examine the impact of two different α/β3-substitution 
patterns, ααβαααβ (6) and αααβ (7) (Figure 25) in a tertiary structure context; these patterns 
previously led to effective structural and biological mimics in BH3 domain-derived helical 
peptides.106 Both templates were designed to place β-residues distant from the hydrophobic core 
of GB1 as well as surfaces involved in protein-receptor binding. The ααβαααβ pattern was 
expected to display the backbone methylene units as a stripe opposite of the hydrophobic core of 
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GB1. In contrast, the αααβ pattern should arrange the backbone methylene units as a rotated 
stripe along the α-helix. 
 
 
 
Figure 26. CD scans at 25 °C and thermal melts of 40 µM wild-type 1 and mutants 6 and 7 in 20 
mM phosphate buffered water pH 7. 
 
 
The CD scans of 6 and 7 are significantly different in shape and magnitude from that of 
wild-type 1 (Figure 26). The minimum at 209 nm is consistent with minima observed for other 
α/β helices.110 The notably larger magnitude of the molar ellipticity of 7 compared to 6 could 
suggest that the αααβ pattern leads to a greater helical character in GB1 than the ααβαααβ 
pattern. However, changes to the peptide backbone have resulted in altered CD spectra relative to 
natural proteins and as such, CD spectra of unnatural backbones may not accurately reflect the 
extent of folded structure in solution. Interestingly, thermal melts reveal a lower Tm for 7, 
corresponding to a lower folded stability than mutant 6 (Table 2). 
 
 
 39 
Table 2. Melting Temperatures and Changes to Free Energy of Folding for Helix Mutants 6-7. 
Sequence Tm  (°C) 
ΔTm  
(°C)a 
ΔΔGfold 
(kcal/mol)a 
6 61.6 ± 0.1 -19.8 3.5 ± 0.1 
7 56.5 ± 0.1 -24.9 4.1 ± 0.1 
a. Relative to 1. 
 
 
 
Figure 27. Overlay of wild-type GB1 structure (2QMT) with refined crystal structures of 6 
(yellow) and 7 (gray). β3-Residues are colored cyan. 
 
 
Diffraction quality crystals of 6 and 7 were obtained by hanging-drop vapor diffusion and 
used to determine high-resolution crystal structures (1.95 Å and 2.20 Å, respectively, Figure 27). 
Each mutant exhibits high structural homology to the wild-type crystal structure including side-
chain display in the helices. Both substitution patterns displayed the β-residues as expected from 
our design. The β-residues in 6 are aligned on the side of the helix distal from the hydrophobic 
core, while in 7 they form a rotated stripe about the helix. The average backbone dihedrals of β3-
residues (ϕ, θ, and ψ) in both mutants match closely with previously published structures of 
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helices containing β3-residues70 (Table 3). Many native tertiary interactions are preserved in the 
helix-modified mutants, even when the interaction involves a β3-residue (Figure 28). RMSD 
values for 6 and 7 (0.529 Å and 0.927 Å, respectively) relative to wild-type crystal structure 
suggest that the fold of 6 is closer the native fold than that of 7. Additional structural parameters 
of the helices of 1, 6, and 7 were analyzed, but no significant differences in measured values 
were observed (Table 3). 
 
 
Table 3. Comparison of Helical Parameters of α/β Helices and Wild-type GB1 Helix. 
 
 
   
Protein Phi (°) 
Theta 
(°) 
Psi 
(°) 
Radiusa  
(Å) 
Rise/Residuea 
(Å) 
Pitchb 
(Å) 
1 (2QMT)78 - - - 2.3 1.5 6 
6 -106 82 -114 2.4 1.5 5 
7 -108 85 -111 2.4 1.5 6 
2OXJ70c -116 84 -109 2.5 1.5 5 
a. Calculated using HELANAL software.111 
b. Calculated using PS software.112 
c. α/β-helix from coiled-coil.70 
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Figure 28. A) Overlay of helix backbone and side-chains in crystal structures of 6 (yellow) and 7 
(gray). B) Tertiary interaction in the structure of 6 of side-chain from β3-Lys31 with side-chain of Trp43. 
 
 
2.2.3 Sheet 
β-Sheet motifs are ubiquitous in proteins, yet their structural mimicry by foldamers is much less 
understood relative to α-helices. One explanation could be the larger entropic barrier to folding 
in β-sheets; sheet formation requires the precise arrangement of two (or more) β-strands such 
that sufficient hydrogen bonds are formed and hydrophobic side-chains are buried. Pioneering 
studies showed that small cyclic β-residues formed sheet-like structures or fibrils in organic 
solvents.113-115 Few studies have examined sheet mimicry in the more challenging folding 
environment of aqueous solvents.116-118 
Prior work in our lab focused on developing strategies for β-sheet mimicry on unnatural 
backbones. Early designs using a small model hairpin peptide focused on exploring mixed α/β-
backbones to probe the ability of β-residues to influence sheet formation in buffered water.119 
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Two central α-residues in the model hairpin sequence were systematically replaced in a 1:1 
fashion by sixteen different β-residues. The selection of β-residues examined how side-chain 
position (β2 vs β3 vs β2,3), stereochemistry, and backbone cyclization affected the propensity of 
the peptide to fold into a hairpin. Of the 16 monomers explored, only three were capable of 
hairpin formation in mixed α/β-peptides. It was further shown by 2D-NMR analysis that only 
two peptides, containing either enantiomer of a β2,3-residue, had native hairpin-like folds in 
aqueous solution. Unfortunately, in all cases, the 1:1 α/β substitution led to an inversion of the 
backbone amide as well as the side-chain (Figure 29), making it unsuitable for sheet 
modifications in tertiary structures. 
 
 
 
Figure 29. Change in side-chain display in hairpin peptide as a result of 1:1 α/β substitution. β-
Residues are colored cyan and side-chain atoms of key hydrophobic core residues are shown as gray 
spheres. Data from reference 119. 
 
 
To circumvent the unfavorable inversions introduced by 1:1 α:β substitutions, our lab 
previously explored four alternate strategies in a longer model hairpin peptide derived from the 
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C-terminal hairpin of GB1: αα→ β2 or β3 (I), αα→ β2,3 (II), αα→ β3-β2 (III), and αα→ β2,3-β2,3 
(IV). These designs examined the role of two orthogonal variables on sheet backbone 
modification: 1) backbone length relative to the replaced αα segment and 2) backbone 
preorganization of β-residues (Figure 30).120 Designs I and II are 2:1 α:β substitutions whereas 
III and IV are 2:2 α:β replacements. Of the designs investigated, I, II, and IV led to α/β-peptides 
with hairpin folds by 2D NMR analysis. Peptides based on Design III likely failed to fold as 
designed because of the significant increase in backbone flexibility introduced by a 2:2 α:β 
substitution. Relative to the all α-residue model sequence, each design introduced an 
approximately 0.5 kcal/mol energetic penalty towards folding per substitution. Despite this 
destabilization, NMR solution structures confirmed the presence of a hairpin-like fold in the α/β 
peptides. 
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Figure 30. Dipeptide substitution designs for hairpin mimicry in mixed α/β-peptides. R is the 
side-chain group(s) of the corresponding α-residue(s). Adapted with permission from reference 120.  
 
 
Having demonstrated that α/β oligomers based on a model hairpin sequence can fold akin 
to that of the native peptide, we set our sights on modifying the sheet of GB1. Sheet mutants 8 
and 9 were synthesized and examined for their ability to retain the tertiary fold of GB1 (Figure 
31). 8 utilizes a 2:1 α:β replacement strategy from Design I while a 2:2 α:β akin to that of Design 
III was used in 9. Synthetic difficulties associated with monomer synthesis precluded the 
investigations of β2,3 residues in GB1. 
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Figure 31. Sequences of GB1 sheet mutants 8 and 9. R is the side-chain group of the 
corresponding α-residue. 
 
 
Disappointingly, CD data of 8 and 9 did not show evidence of tertiary folding behavior 
(Figure 32). The CD spectrum of 8 was indicative of a random coil structure. Very low 
magnitude minima at 208 nm and 222 nm, wavelengths characteristic of a canonical α-helix, 
were observed in the scan of 9. The large difference in both shape and magnitude of the spectra 
of 8 and 9 from that of wild-type GB1 suggested that neither has significant tertiary structure. 
Thermal melts of 8 and 9 support the conclusions drawn from the CD scans as little to no change 
in signal at 220 nm was seen in the sheet mutants, precluding an accurate Tm determination. 
Collectively, the CD data indicated that other substitution strategies would be required for 
modifying the sheet of GB1 and underscored the differences between model hairpin peptides and 
larger protein sheet systems. 
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Figure 32. CD scans at 25 °C and thermal melts of 40 µM GB1 sheet mutants 8 and 9 in 20 mM 
phosphate buffered water, pH 7. 
 
 
N-methyl-α-residues, methylated variants of α-amino acids at the backbone nitrogen 
atom, have been used in small sheet peptides to study aggregation prone sequences especially 
those from neuronal121 and pancreatic disorders.122 N-methyl residues are advantageous in these 
systems because of the replacement of a backbone hydrogen bond donor with a methyl group 
that disfavors edge to edge association of strands. We hypothesized that these residues would be 
suitable for sheet backbone modification in GB1 because relative to β-residues, N-methyl residue 
incorporation does not increase the flexibility or length of the backbone, an important 
consideration for maintaining tertiary interactions in the native fold. 
Two N-methyl residues were introduced into the central residue of the outer strands of 
GB1 to generate mutant 10 (Figure 33). These locations were chosen to avoid disruption of 
interstrand hydrogen bonds necessary for sheet formation. From modelling analysis based on the 
wild-type crystal structure (2QMT), the unnatural N-methyl groups should extend towards 
solvent and not disrupt the fold of GB1. 
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Figure 33. Sequence of N-Methyl GB1 sheet mutant 10. R is the side-chain group of the 
corresponding α-residue. 
 
 
As expected, a CD scan of 10 shows a native-like spectrum with a somewhat lower 
magnitude at 220 nm, perhaps indicative of reduced sheet content (Figure 34). Thermal melts of 
10 yield a Tm of 75.6 °C resulting in a ΔΔGfold of 0.9 kcal/mol relative to 1. Given the 
conservative nature of the modification, the slightly destabilized folded state of 10 is 
unanticipated but may be a result of tertiary amide cis/trans isomerization or changes in 
solvation of the protein brought about by the exposed and hydrophobic N-methyl groups. The 
difference in free energy for cis and trans conformations of tertiary amides is much smaller than 
in secondary amides and many tertiary amides have been shown to display both conformations in 
proteins.123-124 
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Figure 34. CD scans at 25 °C and thermal melts of 40 µM wild-type 1 and mutant 10 in 20 mM 
phosphate buffered water pH 7. 
 
 
2.2.4 Turns 
Protein tertiary folding typically requires a reversal of backbone direction at several points in the 
sequence. This reversal is often realized by the β-turn, and β-turn mimics have been extensively 
studied. For clarity, a β-loop is defined herein as a group of adjacent residues in a protein or 
peptide that contain the β-turn residues as well as an N-H to O=C intramolecular hydrogen bond 
between the first (i) and last (i + n) residue (Figure 35). The β-turn residues are the residues 
between the first and last residue of a β-loop (i + 1 to i + n-1). The turn residues reverse the 
direction of the polypeptide chain and typically do not have any intramolecular backbone 
hydrogen bonds. The canonical β-loop spans four residues (n = 3) and is stabilized by an 
intramolecular hydrogen bond between residues i and i + 3 that additionally serves as the first 
hydrogen bond of the β-sheet. β-turns are classified by the ϕ and ψ bond dihedrals of residues i + 
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1 and i + 2 and fall into one of nine turn types,125 the most prevalent of which are I, II, Iʹ, and IIʹ. 
Types I and II differ from Iʹ and IIʹ in the signs of the ϕ and ψ bond dihedrals.  
 
 
 
Figure 35. Example of a canonical four-residue β-loop, i – i + 3. β-Turn residues are colored 
magenta. Side-chains are omitted for clarity. Dotted black lines indicate interstrand hydrogen bonds. β-
Loop adapted from GB1 (PDB: 2QMT). 
 
 
β-Turn mimics have been developed to explore the kinetics of β-sheet nucleation and 
control the propensity to promote turns in model peptides.64, 67, 69, 126 Prior work investigated the 
nucleation capacity of six different β-turn mimics in variants of a Pin1 WW domain model 
peptide (Figure 36).69 The study found that the fastest nucleators were those that matched the 
preferred dihedral angles of the model peptides turn type. In separate work, a dibenzofuran-based 
turn mimic was incorporated into the N-terminal β loop of GB1;65 the resulting mutant had nearly 
identical folded stability as the wild-type protein. 1,2,3-triazoles have also been explored as β-
turn mimics.54, 127 In a larger protein context, 1,4 and 1,5 disubstituted 1,2,3-triazoles were 
 50 
explored as cis-peptide bond mimics in a β-turn of RNase A.54 1,5 disubstituted triazoles were 
shown to be superior than both 1,4 triazoles and the native backbone at recapitulating cis-peptide 
bonds as shown by the higher catalytic activity of the mutant enzyme.  
 
 
 
Figure 36. Examples of several β-turn mimics studied in the literature. 
 
 
As closer analogs of α-amino acids, D-amino acids have been used as turn inducers in 
short peptides. D-Pro-Gly segments in two-residue β-loops have been shown to strongly promote 
β-hairpin structures in small peptides.62, 128-129 In these two-residue loops, types Iʹ and IIʹ are 
favored for β-hairpin formation over other turn types. In contrast, four-residue turns often fall 
under Type I or II; surveys of four-residue turns reveal a high frequency for L-proline at position 
i of the turn.130-131 
Cα-methyl residues such as aminoisobutyric acid (Aib) are known to be strong helix 
promoters in short peptides and proteins.35, 132 This is due to the restricted Ramachandran space 
of Cα-methyl residues resulting from the sterics of the α-methyl group. The backbone 
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conformational preferences permits far fewer structures than α-residues. It has been shown that 
an Aib-Gly dipeptide segment can induce turns in short hairpin peptides in water with a similar 
efficacy as D-Pro-Gly.68  
 
 
 
Figure 37. Sequences of turn mutants 11-13. 
 
 
We designed three proteins, 11, 12, and 13 (Figure 37) to examine the effects of turn 
replacement in GB1. Protein 11 replaces the central two residues of each β-loop with D-Pro-Gly. 
In 12, four-residues of the native turns are entirely replaced with D-Pro-Gly to create two type 
Iʹ/IIʹ two-residue β-turns. In modifying each β-turn in GB1 to be a two-residue turn, a mirror 
image turn promoter was hypothesized to be more favorable than other turn type promoters. 
Mutant 13 retains the C-terminal turn’s modification from 12 but uses an alternate strategy for 
the N-terminal turn replacement; the two turn residues are replaced with an Aib-Gly segment. As 
Aib-Gly is an achiral segment, it may be better accommodated in GB1 as opposed to the chiral 
D-Pro-Gly turn by enacting less of a chiral preference on the local folding environment. 
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Figure 38. CD scans and melts of 40 µM turn mutants 11-13 in phosphate buffered water pH 7. 
 
 
CD spectra of 11, 12, and 13 showed similar curve shape yet reduced minima intensity of 
both proteins relative to the wild-type 1 (Figure 38), possibly suggesting the presence of a less-
prominent tertiary structure. Hybrid turn mutant 13 displayed an absorbance with a shape and 
magnitude closer to that of 1. Thermal melts of mutants 11, 12, and 13 suggested that the D-Pro-
Gly segment strongly destabilized the type I turn of the N-terminal hairpin while promoting type 
Iʹ/IIʹ turns as mutant 12 exhibited higher thermal stability than 11. Despite having two fewer 
residues, the shortened C-terminal turns appeared to be well tolerated in GB1 as shown by the 
higher folded stabilities of 12 and 13 relative to 11. In contrast, modification of the N-terminal 
turn with either Aib-Gly or D-Pro-Gly was unfavorable, perhaps due to a native turn type 
mismatch. It was possible that replacing the four-residue β-loop of the N-terminus as in 12 and 
13 resulted in removal of the first hydrogen bond of the β-hairpin, causing a change in the 
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hydrogen bond register of the β-hairpin. The hydrogen bond register is important to β–sheet 
formation and changes to the native register may disrupt β-sheet formation.  
Only 13 was able to be crystallized and diffracted to give a high resolution structure (2.00 
Å). The structure shows a native-like tertiary fold in close agreement to wild-type GB1 with a Cα 
RMSD of 0.45 Å. As hypothesized, the N-terminal turn shows a turn type mismatch that likely 
reduced the thermal stability of 13 (Figure 39). In one of the chains of the asymmetric unit, the 
N-terminal turn appears to more disordered as revealed by locally elevated B-factors. Overlays 
of the C-terminal turns of 1 and 13 supported the observation from CD melts that the shortened 
turn is well accommodated and does not significantly alter the position of the β-strands that form 
part of the central β-sheet.  
 
 
 
Figure 39. Close-up of A) N-terminal and B) C-terminal turns from 13 (yellow) overlaid with 
those from wild-type GB1 (magenta) (2QMT). 
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2.3 COMBINED BACKBONE MUTATIONS 
2.3.1 “All” Mutant 
As described throughout the chapter, we systematically explored backbone alterations in the 
secondary structure elements of GB1 through several unnatural residue types. Although every 
modification was destabilizing to the tertiary fold, nearly all mutants had evidence of native-like 
folding behavior through CD spectra and/or X-ray crystallography. We were curious as to how 
the individual secondary structure mutations would affect the folding thermodynamics of GB1 
when combined in one sequence.  
The backbone sequences of the mutants with the highest Tm, approximately equivalent to 
the most stable fold, were combined into the design of All mutant 14 (Figure 40). For the turn 
mutants, the sequence of 13 was selected due to its ability to yield diffraction quality crystals and 
confirmed native-like three dimensional fold. 14 bears the side-chain sequence of wild-type GB1 
on a mixed backbone composed of ~ 20 % unnatural residues. 
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Figure 40. Sequences of wild-type GB1 1 and mutants used to design All mutant 14. R is the 
side-chain group of the corresponding α-residue. 
 
 
All mutant 14 had characteristic signatures of its constitutive design elements as observed 
by CD: an α/β-helix (minima at 209 nm) and wild-type GB1 sheet (broad absorbance centered on 
218 nm) (Figure 41). Assessment of folded structure by CD scans alone, however, is not reliable. 
Stronger evidence for a tertiary fold in 14 came from a thermal melt. The denaturation curve of 
the All mutant was two-state and cooperative. The low Tm of 31 °C translated to an approximate 
∆∆Gfold of 8 kcal/mol relative to wild-type GB1 (Table 4). This high destabilization closely 
matched the sum of the energetic penalties of each individual secondary structure modification, 
suggesting that the combination of several different strategies for backbone alteration in proteins 
could lead to foldamers with predictable stabilities.  
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Figure 41. CD scans at 25 °C and thermal melts of 40 µM wild-type 1 and mutant 14 in 20 mM 
phosphate buffered water pH 7. 
 
 
Table 4. Summary of Folding Thermodynamics for Wild-type GB1 and Mutants. 
Sequence 2 º modified 
Tm  
(°C) 
ΔTm  
(°C)a 
ΔΔGfold 
(kcal/mol)a 
1 - 81.4 ± 0.1 - - 
5 loops 77.6 ± 0.1 -3.8 0.6 ± 0.1 
6 helix 61.6 ± 0.1 -19.8 3.2 ± 0.1 
10 sheet 75.6 ± 0.1 -5.8 0.9 ± 0.1 
13 turns 67.6 ± 0.1 -13.8 2.2 ± 0.1 
14 all ~ 31b -50 ~ 8 
a. Relative to 1. 
b. A complete folded baseline was not observed. 
 
 
2.3.2 “NuG-All” Mutant 
As stated in the introduction, the hypothesis guiding our designs is that every protein has two 
orthogonal sequences: side-chain and backbone. Improvements or deteriorations from changes to 
one sequence should equivalently affect the orthogonal sequence provided the three dimensional 
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structure of the oligomer is unchanged. The CD data on 14 suggested the presence of a tertiary 
structure albeit with low folded stability. Due to the likely similar folded state, wild-type GB1 
and All mutant 14 could serve as a model to test our two-sequence hypothesis. 
Proteins 1 and 14 share nearly an identical side-chain sequence, yet the backbone 
sequence differs significantly. If the side-chain sequence were to be altered and found to be 
stabilizing to the wild-type protein, then that same side-chain modification should stabilize the 
All mutant as well. Previous computational work on GB1 designed an all α-residue mutant of 
GB1, referred to as NuG, that had an identical folded state that was approximately 5 kcal/mol 
more stable than native GB1.133 The side-chain sequence of NuG (15) was grafted onto the 
backbone of the All mutant to generate NuG-All mutant 16 (Figure 42). 16 has the identical 
backbone sequence of 14 and the high stability fold-encoding side chain sequence of NuG. 
 
 
 
Figure 42. Sequences of wild-type protein 1, all mutant 14, NuG 15, and NuG-All mutant 16. 
Underlined residues indicate side-chain sequence alterations relative to 1. R is the side-chain group of the 
corresponding α-residue. 
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Gratifyingly, the tertiary fold of 16 was much more stable than 14 as revealed by CD 
thermal melts (Figure 43, Table 5). The Tm of NuG mutant 16 was nearly identical to that of 
wild-type GB1, translating to an approximately 8 kcal/mol stabilization over All mutant 14. The 
folding transition of 16 is somewhat less cooperative than either 14 or wild-type 1. A similar 
reduction in folding cooperativity was previously observed in NuG.133-134 Side-chain sequence 
alterations in GB1 can change the folding mechanism134 and could explain the differences in 
folding between 16 and 1. Despite the large difference in folding free energies between 14 and 
16, CD scans revealed matching signatures underscoring the limitations of CD spectra of 
proteins with unnatural backbones. Native-like cooperative unfolding transitions were observed 
for 16. The observation that side-chain mutations stabilizing to the wild-type protein also 
stabilize a highly modified backbone variant provided further evidence for the native-like folds 
of 14 and 16. Unfortunately, we were unable to obtain crystals of 14 or 16 to confirm the folded 
structure of either protein.  
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Figure 43. CD scans at 25 °C and thermal melts of 40 µM wild-type 1 and mutants 14 and 16 in 
20 mM phosphate buffered water pH 7. 
 
 
 
Table 5. Summary of Folding Thermodynamics for Wild-type GB1 and All Mutants 
Sequence 2 º modified 
Tm  
(°C) 
ΔTm  
(°C)a 
ΔΔGfold 
(kcal/mol)a 
1 - 81.4 ± 0.1 - - 
14 all ~31b -50 ~8 
16 NuG-all ~82c ~0 ~0 
a. Relative to 1. 
b. A complete folded baseline was not observed. 
c. A complete unfolded baseline was not observed. 
 
2.4 CONCLUSIONS AND OUTLOOK 
This work has shown that a native protein with a defined tertiary fold can serve as a blueprint for 
the design of backbone-modified variants. The folded structure of GB1 possesses every 
secondary structure common in proteins and each could be modified individually and in tandem. 
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Although the backbone alterations were destabilizing to the tertiary fold in all cases, nearly all 
mutants retained the sequence-encoded fold of the wild-type and high resolution crystal 
structures of several mutants were obtainable. Combining several secondary structure 
modifications into one sequence led to a near-additive destabilization of the folded state 
suggesting that the stability of highly modified mutants could be reliably predicted from 
individual backbone alterations. It should then be possible to use improved substitution strategies 
to increase the folded stability of foldameric variants of proteins. 
The collective dataset also bears favorably on our two sequence design hypothesis: 
backbone and side-chain sequences are orthogonal design variables inherent to every protein. 
The folded stabilities of both wild-type protein 1 and All mutant 14 were greatly increased by 
changing the side-chain sequence to that of NuG. Stated another way, replacing the all α-residue 
backbone of either wild-type GB1 or the optimized NuG variant 15 with that of 14 was highly 
destabilizing to the sequence-encoded folds. This raises the possibility of using a protein of 
interest to design a proteolytically resistant variant and modulate the folded stability through 
side-chain modifications. Protease-resistant backbones that display the complex folds of 
therapeutically relevant proteins could facilitate protein-protein interface modulation, a 
challenging drug development area.135 
Our work explored several classes of unnatural residues: Cα-methyl α-residues, N-methyl 
α-residues, D-α-residues, β-residues, and PEG-derived residues. It would be worthwhile to 
explore additional classes as well as different substitution strategies in an attempt to improve the 
thermodynamic stabilities of the GB1 mutants. Establishing the relationship between proteolytic 
stability and backbone sequence, determining the physical rationale behind why certain unnatural 
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residues destabilize protein structures are investigated in subsequent chapters. The applicability 
of the tertiary design rules established herein to other protein sequences remains to be measured. 
2.5 EXPERIMENTAL 
2.5.1 General Information 
Solvents and all other reagents were purchased from Aldrich, Baker, EMD, or Fisher and used 
without further purification. HOBt was purchased from Anaspec Inc. HCTU, NovaPEG Rink 
Amide Resin, and Fmoc-protected α-amino acids were purchased from Novabiochem. Fmoc-
protected β3-amino acids were purchased from Aapptec. Fmoc-Aib-OH, Fmoc-D-Pro-OH, and 
the residues preceding adjacent residues were coupled with PyAOP in place of HCTU. 
Microcleavages were taken after all PyAOP and pseudoproline dipeptide couplings. 
2.5.2 Protein Synthesis 
Optimization of the chemical synthesis of GB1 was developed in order to effectively obtain 
sufficient amounts of wild-type and synthetic proteins for characterization. Before describing the 
final procedures used for SPPS of GB1, the development of the optimized method is presented 
below. 
 
 62 
2.5.2.1  General Considerations for Fmoc-SPPS of GB1 
 
Solid-phase peptide synthesis has been vastly improved since it was invented in 1963.136 Modern 
chemical syntheses of proteins utilize microwave-assisted Fmoc-SPPS. A general procedure is as 
follows. Resin is allowed to swell in DMF before a coupling reaction is carried out. Four 
equivalents of a pre-activated mixture of a coupling reagent and the last amino acid of the 
sequence (for example, Glu56 in GB1) in a polar aprotic solvent such as NMP are added. The 
reaction vessel is heated with microwave radiation stirred. The resin is washed three times with 
DMF before a solution of 20% (v/v) 4-methyl piperidine in DMF is added. Deprotection 
reactions are similarly carried out under microwave heating. After washing three times with 
DMF, the cycle is repeated starting with the coupling reaction until the peptide sequence is 
completed. Treatment of the resin with an acidic cleavage cocktail removes side-chain protecting 
groups and cleaves the peptide from resin. The crude peptide is then subjected to reversed-phase 
HPLC purification methods. Peptides in excess of 90 residues have been prepared using similar 
methods.137 
 
 
 
Figure 44. Crude HPLC traces from GB1 microwave-assisted SPPS before and after 
optimization. 
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Although GB1 is only 56 residues in length, we found that total chemical synthesis of 
GB1 and backbone-modified analogues required modification of standard microwave-assisted 
Fmoc-SPPS methods. To account for the increased sequence length and hydrophobicity of GB1, 
Fmoc-amino acid and HCTU equivalents were increased from four to six relative to resin. We 
initially synthesized the C-terminal 28 residues of protein 1 by this method. HPLC traces of 
crude material obtained showed desired product along with several deletion products (Figure 44). 
Poor crude purity resulted partially from aspartimide formation, a well-known problem of solid-
phase peptide synthesis138 especially when used with microwave irradiation.139 To suppress 
aspartimide formation, the deprotection conditions were changed to 0.1 M HOBt in 5 % 
piperazine in DMF.139 Deletion products may be derived from peptide aggregation on resin due 
to the hydrophobic nature of commonly used amino acid side-chain protecting groups. To 
mitigate aggregation of the growing peptide chain, pseudoproline dipeptides were incorporated at 
two positions in the sequence (Figure 45), proximal to the β-strands in the full-length protein. 
Pseudoproline dipeptides disfavor aggregation of the growing peptide chain through disruption 
of intermolecular and intramolecular hydrogen bonding.140 Significant increases in crude purities 
were observed in subsequent syntheses. 
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Figure 45. Location of pseudoproline dipeptide residues in synthesis of wild-type 1 sequence. 
The oxazolidine-based backbone is removed under acidic cleavage conditions to yield two α-residues. 
 
 
As an alternative to microwave-assisted SPPS, we employed room temperature Fmoc-
SPPS methods using an automated peptide synthesizer for some GB1 analogues. The best crude 
purities were obtained using a further optimized methodology. Coupling reactions times were 
increased from 30 minutes to 45 minutes. Two deprotection reactions were performed per amino 
acid with 4-methyl piperidine in DMF for four minutes. It was found that deletions occurring at 
Glu56 and Glu15 were often the major side products of syntheses. Double coupling of these 
residues further improved crude purities and yields (Figure 46). 
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Figure 46. Crude HPLC trace from GB1 SPPS by automated room temperature methods. 
 
 
2.5.2.2  Optimized Fmoc-SPPS Methods 
 
Two different SPPS protocols were utilized to synthesize proteins 1-14 and 16. For all syntheses, 
after the final deprotection reaction, the resin was washed three times with 3 mL of 
dichloromethane followed by three 3 mL washes of methanol. After drying in a vacuum 
desiccator, the resin was cleaved.  
 
Microwave-assisted synthesis. Proteins 1-4 were synthesized by this method. Coupling 
reactions were carried out using six equivalents of protected amino acid, six equivalents HCTU, 
and eight equivalents of DIEA in 1.2 mL of N-methylpyrrolidinone relative to resin. After two 
minutes of preactivation, the activated amino acid was added to resin and heated with microwave 
radiation to 70 °C over two minutes. The reaction was held at 70 ºC for four additional minutes. 
Deprotection reactions were performed with 2.0 mL of 5% piperazine with 0.1 M HOBt in DMF. 
The resin was then heated to 80 ºC over two minutes with microwave radiation. The reaction was 
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maintained at 80 ºC for an additional two minutes. After each coupling and deprotection step, the 
resin was washed three times with 3 mL of DMF for 40 seconds each. Pseudoproline dipeptides 
were incorporated into proteins by coupling at room temperature for 45 minutes with identical 
volumes and reagents as all other Fmoc-protected amino acids.  
 
Automated synthesis. Proteins 5-14 and 16 were synthesized on a PTI Tribute automated 
synthesizer on 70 µmol scale of NovaPEG Rink Amide resin. Coupling reactions were 
performed using 3 mL of a 0.4 M N-methylmorpholine in DMF solution added to 7 equivalents 
of the Fmoc-amino acid and HCTU. After a two minute preactivation, the activated amino acid is 
added to the resin and vortexed for 45 minutes. Deprotection reactions were carried out twice 
with 3 mL of a 20% v/v solution of 4-methylpiperidine in DMF for four minutes. After each 
coupling or deprotection the resin was washed four times with 3 mL of DMF for 40 seconds 
each. After the final deprotection reaction, the resin was washed three times with 3 mL of 
dichloromethane followed by three 3 mL washes of methanol. After drying in a vacuum 
desiccator, the resin was subjected to cleavage. 
 
Cleavage. Peptides were cleaved from resin by treatment with a solution of 94% TFA, 1% TIS, 
2.5% water, and 2.5% EDT. Crude peptides were precipitated by addition of cold diethyl ether. 
The solid was pelleted by centrifugation and dissolved in 6 M guanidinium chloride, 25 mM 
sodium phosphate, pH 5.7. This solution was then subjected to purification.  
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2.5.3 Protein Purification and Characterization 
Each protein was purified by preparative C18 reverse-phase HPLC using gradients between 
0.1% TFA in water and 0.1% TFA in acetonitrile. The identity of each was confirmed by MS 
analysis on a Voyager DE Pro MALDI-TOF instrument (Table 6). Following HPLC purification, 
each protein was subjected to anion-exchange chromatography on a monoQ 5/50GL column, 
(GE Healthcare) using 0.02 M Tris buffer at pH 8 and eluted with increasing concentrations of 
KCl. Final protein samples were ≥ 95% pure by analytical reverse-phase HPLC (Figure 47). 
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Figure 47. Analytical HPLC chromatograms of purified proteins 1-14, and 16. 
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Table 6. MALDI-TOF MS Data for Proteins 1-14, and 16. 
# [M+H]+ m/z (avg.) Calculated Observed 
1 6179.6 6178.6 
2 6024.5 6023.9 
3 6052.5 6052.1 
4 5898.4 5897.7 
5 6207.7 6204.4 
6 6235.8 6232.8 
7 6235.8 6237.3 
8 5789.3 5791.5 
9 6271.9 6274.6 
10 6207.7 6207.5 
11 6085.5 6089.2 
12 5672.1 5674.0 
13 5831.2 5828.5 
14 5943.5 5944.1 
16 5995.6 5997.8 
 
 
2.5.4 Competition ELISA.  
ELISAs were performed using pre-coated Protein G plates (Sigma-Aldrich). Before use, assay 
plates were blocked for 2 h at ambient temperature in a humid atmosphere with dilution buffer 
(25 mM sodium phosphate with 0.15 M NaCl, pH 7.4, 0.05% (v/v) Tween-20, 3% BSA). Stock 
plates were prepared containing serial dilutions of each protein in dilution buffer. 10 µL of this 
protein stock was then added to 80 µL of dilution buffer, followed by addition of 10 µL of 0.25 
µg/mL rabbit anti-goat IgG-HRP (Biorad) conjugate antibody to wells. Plates were mixed, 
incubated for 1 h at ambient temperature, and washed with wash buffer (25 mM sodium 
phosphate with 0.15 M NaCl, pH 7.4, 0.05% (v/v) Tween-20) four times for 10 seconds each. 
100 µL of TMB Substrate System (Sigma) was added to wells, mixed, and incubated for 20 
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minutes at ambient temperature. 100 µL of 1 M HCl was then added to wells and plates were 
read at 450 nm on a Modulus II multimode plate reader (Turner Biosystems). Reported values 
are averages of six replicate measurements. Each assay plate included control wells containing 
only TMB Substrate System that were developed as described above and used to determine the 
A450 value for 0 % binding of antibody to well. Data were fit to a sigmoidal dose-response 
curve with variable slope using GraphPad Prism. The Hill slope was found to be -0.65; values 
less than 1 have previously been observed for monovalent inhibitors and multivalent receptors in 
a competition ELISA.141 
 
2.5.5 Circular Dichroism Spectroscopy.  
CD measurements were made on an Olis DSM17 Circular Dichroism Spectrometer. 
Measurements were carried out on samples consisting of 40 µM protein in 20 mM sodium 
phosphate buffer, pH 7.0 with 2 mm quartz cells. Scans were taken at 25 ºC over the range of 
200-260 nm with 1 nm increments and a 1 nm bandwidth. Scan data were smoothed by the 
Savistsky-Golay method as implemented in GraphPad Prism. Melts were monitored at 220 nm 
over the range of 4 ºC to 98 ºC with 2 ºC increments, a dead band of 0.5 ºC, and a 2 minute 
equilibration time for each temperature point. All measurements were baseline corrected for 
blank buffer. Temperature-dependent CD data were fit to simple two-state unfolding model 
using GraphPad Prism to obtain melting temperature (Tm) and enthalpy of folding at Tm (ΔHfold). 
The change in free energy of folding for each mutant relative to wild-type (ΔΔGfold) was 
calculated according to equation 2.1: 
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Equation 2.1 
m
m
foldfold T
THG ∆∆=∆∆  
where ΔHfold is the enthalpy of folding at Tm for the wild-type, Tm is the melting temperature for 
the wild-type, and ΔTm is the change in melting temperature for mutant relative to wild-type.96-97 
This relationship assumes that the heat capacity change of folding is identical for the mutant and 
the wild-type. 
 
2.5.6 Gel Permeation Chromatography.  
GPC was performed on a Superdex 75 10/300 GL column (10 x 300 mm, 24 mL bed volume, 13 
µm average particle size, GE Healthcare). The column was equilibrated with 150 mM NaCl in 20 
mM sodium phosphate, pH 7.0. Protein samples (40 µM protein in equilibration buffer) were 
loaded onto the column and eluted at a flow rate of 1.0 mL/min.  
2.5.7 Molecular Dynamics. 
MD simulations were performed by collaborators (Eli Musselman and Adrian Elcock, University 
of Iowa). Constructs for proteins 1-4 were modeled starting from a published 1.05 Å crystal 
structure of GB1 from Staphylococcus aureus (PDB 2QMT). In all cases, the first two residues 
were mutated from Met-Gln- to Asp-Thr- and the C-terminal Glu residue was amidated so as to 
be consistent with the corresponding experimental sample. The initial structures for the three 
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PEG-chimeras were completed by deleting the sidechains of the appropriate amino acids and 
altering their backbone N-Cα-C atoms to the C-C-O atoms of the PEG repeating unit.  
 
MD simulations were performed in explicit solvent using GROMACS 4 software.142-145 Amino 
acid residues were modeled with the OPLS-AA forcefield146 and PEG residues were modeled 
using the TraPPE-UA parameters developed by Fischer et al.147 In separate work (Musselman & 
Elcock; manuscript in preparation), we have verified that our implementation of the PEG 
parameters produces conformational behavior consistent with that seen in previous simulation147-
148 and experimental149 studies. In order to maintain consistency of the force fields as far as 
possible, all pairwise interactions involving PEG atoms were treated using Lorentz-Berthelot 
mixing rules,150 otherwise standard OPLS-mixing rules151 were used. Each protein construct was 
immersed in a cubic (periodic) simulation box of side 60 Å, with approximately 7000 water 
molecules added; in order to electrically neutralize each system, 2 or 3 Na+ ions were added 
depending on the net charge of the construct. In all cases water was described by the TIP3P 
model152 and Na+ ions were modeled using Aqvist’s parameters.153 
 
Prior to MD simulation all systems were first energy minimized using the steepest descent 
algorithm for 1000 steps and then incrementally heated to 298 K in 50K intervals over the course 
of 500 ps. Each system was then equilibrated for a further 10.5 ns before the production phase of 
the simulation was begun. Each construct was simulated for 1 µs of production time; system 
coordinates were saved at intervals of 0.1 ps for subsequent analysis. All simulations were 
performed in the NPT ensemble: pressure (1 atm) was maintained with the Parrinello-Rahman 
barostat154 and temperature (298 K) was maintained using the Nosé-Hoover thermostat.155-156 
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Cutoffs for both the short-range electrostatic and van der Waals interactions were set to 10 Å; all 
long-range electrostatic interactions were calculated using the Particle Mesh Ewald (PME) 
method.157 In all simulations covalent bond lengths were constrained using the LINCS 
algorithm,158 enabling a 2.5 fs time step to be used. Each 1 µs production simulation required ~3 
weeks of dedicated time on a 48-core Dell R815 server. MD trajectories for 1-4 were analyzed 
using various tools in the GROMACS package to extract time-dependent RMSD plots, dihedral 
trajectories and distributions, and dihedral autocorrelation functions. The dihedral 
autocorrelation functions were fit to two-phase exponential decays using GraphPad Prism. 
2.5.8 Crystallization of Proteins 
Diffraction-quality crystals were obtained for proteins 5-7 and 13 by hanging drop vapor 
diffusion. ~17 mg/mL solution of protein in water was mixed (1 µL + 1 µL) with well buffer 
(Table 7). The drop was allowed to equilibrate at room temperature (5, 7, 13) or at 4 ºC after two 
weeks at room temperature (6).  
 
 
Table 7. Crystallization Conditions for Proteins 5-7 and 13. 
Protein Buffer Precipitant(s) 
5 100 mM NaOAc pH 4.6 16% PEG 3350 
6 150 mM NaOAc pH 4.6 20% PEG 4000 
7 100 mM NaOAc pH 4.6 30% isopropanol, 0.2 M CaCl2 
13 100 mM NaOAc pH 4.6 8% PEG 4000 
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X-ray diffraction data collection and structure determination was performed by W. Seth Horne. 
A single crystal of each protein was flash frozen in liquid nitrogen after cryoprotection in well 
buffer supplemented with 30% v/v glycerol. Diffraction data were collected using CuKα 
radiation on a Rigaku/MSC diffractometer (FR-E generator, VariMax optics, AFC-Kappa 
goniometer, Saturn 944 CCD detector) equipped with an X-Stream 2000 low temperature system 
operated at 100 K. Raw diffraction data were indexed, integrated, and scaled with d*TREK.  
 
Structure solution and refinement were carried out using the CCP4159 and Phenix160 software 
suites. The structures were solved by molecular replacement using the program Phaser161 with a 
model derived from a published structure of wild-type GB1 (PDB: 2QMT78). Refinement was 
performed by a combination of Refmac162 and Phenix for automated refinement, Coot163 for 
manual model building, and Phenix164 for automated model building. Geometric restraints for the 
β-residues were assembled and used in a custom cif library during refinement.  
 
In the case of protein 6, there was some ambiguity in space group assignment. The diffraction 
pattern readily indexed as tetragonal but analysis of intensities during integration and scaling 
suggested the crystal lattice was actually C2221 with a ≈ b. Molecular replacement in this space 
group was successful, but stalled R/Rfree during refinement indicated the possible presence of 
twinning. Analysis of the diffraction data with Xtriage in the Phenix software suite suggested the 
true space group to be P21 with near perfect pseudomerohedral twinning (twin operator: L, –K, 
H). The raw diffraction data were reprocessed in P21 and structure refinement carried out using 
the twin refinement options implemented in Refmac and Phenix. 
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Table 8. X-ray Diffraction Data and Refinement Statistics for Proteins 5-7, and 13. 
# 5 (4KGS) 6 (4KGR) 7 (4OZA) 13 (4KGT) 
Data Collection     
Unit cell dimensions 
(Å, °) 
a  = 52.2, b = 81.2  
c = 52.1 
α = 90, β = 90, 
γ = 90 
a  = 80.7, b = 35.7,  
c = 46.5 
α = 90, β = 120.4, 
γ = 90 
a = b = 65.9, c = 
21.9 
α = β  = γ = 90 
a = b = 83.8, c = 97.5 
α = β  = γ = 90 
Space group P21 C2 I41 I4122 
Resolution (Å) 32.03–2.00 (2.07–2.00) 
28.27–1.95 
(2.02–1.95) 
23.31-2.20 (2.28-
2.20) 
23.28–2.00  
(2.07–2.00) 
Total observations 97,753 51,377 13,203 166,708 
Unique observations 27,508 8,453 2,418 12,054 
Redundancy 3.55 (2.68) 6.08 (3.64) 5.46 (5.42) 13.83 (13.81) 
Completeness (%) 93.7 (82.7) 99.6 (96.3) 96.6 (98.8) 100 (100) 
I/σ 23.6 (5.1) 16.2 (4.1) 11.0 (3.2) 16.7 (4.5) 
Rmerge (%) 4.4 (20.3) 7.8 (22.5) 10.2 (26.4) 7.6 (39.6) 
Refinement     
Resolution (Å) 32.03–2.00 28.27–1.95 23.31-2.20 23.28–2.00 
R (%) 16.2 17.6 23.3 19.8 
Rfree (%) 19.2 21.7 26.0 21.0 
Avg. B factor (Å2) 23.6 24.9 38.1 39.4 
RMSD     
Bonds (Å) 0.011 0.008 0.007 0.007 
Angles (°) 1.54 1.12 1.14 1.05 
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3.0  FOLDING THERMODYNAMICS OF BACKBONE-MODIFIED PROTEINS 
Some of the results in this chapter have been published in: 
Z.E. Reinert, W.S. Horne. "Folding thermodynamics of protein-like oligomers with 
heterogeneous backbones." Chemical Science. 2014, 5, 3325-3330. 
 
Crystallography data collection and structure refinement were performed by W. Seth Horne and 
Nathan A. Tavenor. Chemical synthesis, purification, and characterization of Cα-methyl 
containing GB1 mutants were performed by Nathan A. Tavenor. 
 
Incorporation of backbone mutations in GB1 were destabilizing to the tertiary fold as observed in 
Chapter 2. One open question was the physical basis for the energetic penalties. We sought to 
answer this by exploring the fundamental folding thermodynamics of proteins with unnatural 
backbones. 
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3.1 HELIX SUBSTITUTION STRATEGIES 
3.1.1 α→β3 Substitution 
Our previous work established that backbone modifications to the helix, loops, sheet, and turns 
of GB1 can be combined without sacrificing the sequence-encoded fold, however, at the cost of 
thermodynamic stability (see Chapter 2). In an orthogonal manner, it was shown that side-chain 
sequence changes that improved the folded stability of the wild-type protein also stabilized a 
highly unnatural backbone variant. This suggests that stabilizing alterations to the backbone 
sequence of a protein would enhance the folded stability as well. One route towards improving 
backbone modification of proteins is to understand the physical principles behind the 
thermodynamic destabilization of current strategies. 
The thermodynamics of protein folding have been a longstanding area of intense 
research.165 For most proteins, folding in water is enthalpically driven and entropically 
opposed.166 In the denatured state, water hydrogen bonds to polar groups on the polypeptide 
chain and forms ordered “icebergs” around exposed hydrophobic groups. The increase in solvent 
entropy from the release of ordered water as a protein folds greatly compensates for the steep 
chain entropic penalty of ordering a peptide into the native conformation. The newly formed 
intrachain hydrogen bonds and burial of exposed hydrophobic surface enthalpically drive folding 
of the protein. In general, the folded state of proteins are marginally (5-15 kcal/mol) more stable 
than the denatured state.166 
Compared to native sequences, the folding thermodynamics of proteins with unnatural 
backbones are much less understood. We set out to examine how unnatural residues can alter 
classical protein folding dynamics. Given their prevalence in our work as well as the literature, 
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we chose to focus initially on α→β3 substitutions in the helix and loops of GB1 (mutants 5-7). 
From a cursory examination, β3-residues would be expected to increase the chain entropic 
penalty toward folding relative to an all α-peptide due to the additional rotatable bond present in 
the backbone. To better understand why β3-residues were unfavorable in the helix, the 
thermodynamic origin of the destabilization, i.e. the enthalpic and entropic changes that result in 
the decreased change in folding free energy, would need to be determined.  
We utilized combined thermal and chemical denaturation experiments monitored by CD 
to obtain detailed thermodynamic data on wild-type 1 (Figure 48) and mutants 5-7. This known 
method167-168 monitors the 220 nm CD signal of a protein as a function of temperature over 
several parallel samples containing incrementally varying amounts of a chemical denaturant such 
as guanidinium chloride. The resulting three-dimensional plot is then fit to a surface using a 
modified Gibbs-Helmholtz equation (see experimental) to obtain changes to enthalpy (ΔH°), 
entropy (ΔS°), heat capacity (ΔCp°), and free energy (ΔG°) upon folding as well as the 
sensitivity of the protein fold to denaturant concentration (m). A fundamental challenge in 
protein thermodynamics is discerning contributions to folding entropy. While it is impossible to 
quantitatively determine changes to ΔSfold from chain and solvent entropies experimentally, ΔCp 
and m provide an indirect measure of changes to solvation of the oligomer. These 
thermodynamic parameters and structural data on the folded state of the mutants can inform 
hypotheses on changes to chain and solvent entropies. 
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Figure 48. Global fit of thermal and guanidinium chloride denaturation of 40µM 1 in 20 mM 
phosphate buffer, pH 7. 
 
 
Thermodynamic data for protein 1 and heterogeneous backbone analogues 5-7 are 
summarized in Table 9. Our results agreed with the general observation that protein folding in 
water is enthalpically favored and entropically opposed169 and previously reported 
thermodynamic values for GB1 using differential scanning calorimetry.95 Importantly, the 
dataset provided detailed information on the relationship between backbone alterations and 
changes to protein folding thermodynamics. 
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Figure 49. Changes in thermodynamic parameters of folding for mutants 5-7 relative to wild-type 
GB1 (1). 
 
Table 9. Thermodynamic Parameters for the Folding Transitions of 1 and 5-7 at 298 K.  
# ΔH° (kcal mol-1) 
TΔS° 
(kcal mol-1) 
ΔG° 
(kcal mol-1) 
ΔCp° 
(kcal mol-1 K-1) 
m 
(kcal mol-1 M-1) 
ΔΔG° 
(kcal mol-1)a 
1 -21.9 ± 0.6 -16.1 ±0.3 -5.8 ± 0.6 -0.60 ± 0.02 -1.80 ± 0.04 - 
5 -19.4 ± 0.4 -14.6 ± 0.3 -4.8 ± 0.5 -0.59 ± 0.02 -1.82 ± 0.04 +1.0 ± 0.8 
6 -18.3 ± 0.4 -15.2 ± 0.3 -3.1 ± 0.5 -0.53 ± 0.02 -2.48 ± 0.05 +2.7 ± 0.8 
7 -15.4 ± 0.4 -12.8 ± 0.3 -2.6 ± 0.5 -0.63 ± 0.02 -2.58 ± 0.05 +3.2 ± 0.8 
a. Relative to 1. 
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In each mutant, α→β3 replacement led to an unfavorable change in folding enthalpy. The 
magnitude of the change in ΔH° relative to 1 depended on location (5 vs 6 and 7) and pattern of 
β3-residue incorporation (6 vs 7, Figure 49). The change in folding enthalpies of loop mutant 5 
and helix mutant 6 were within 1 kcal/mol despite 6 having twice the number of β3-residues 
incorporated into a more demanding helical backbone environment. The αααβ substitution 
pattern of helix analogue 7 was far less enthalpically favorable toward folding than the ααβαααβ 
design of 6. In trying to rationalize the physical basis for the consistently unfavorable enthalpy 
change accompanying α→β3 substitution in proteins 5-7, we were drawn to recent work 
exploring the importance of orbital interactions in protein folding.170 Partial donation of a 
backbone carbonyl oxygen np electrons into the empty π* of the subsequent backbone carbonyl is 
thought to stabilize helical conformations. As backbone-elongated analogues of α-residues, β-
residues can only act as donors and not acceptors for this possible orbital interaction. Thus α→β3 
replacement would lead to a loss of one interaction per substitution resulting in an enthalpic 
penalty (Figure 50). 
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Figure 50. Putative n→π* interactions in helices of wild-type GB1 and 6. Dotted lines indicate 
orbital interactions between np electrons of carbonyl oxygens and π* orbital of neighboring carbonyl 
carbons. 
 
 
Replacement of α-residues with β3-analogues was expected to be entropically 
destabilizing towards folding due to the additional degree of backbone conformational freedom 
that would raise the entropy of the unfolded state. Instead, fits of the global denaturation curves 
of 5-7 revealed that incorporation of β3-residues into the loops or helix of GB1 was entropically 
favorable towards folding. As observed with the change in folding enthalpies, the magnitude of 
the changes in ΔS° depended on location and pattern of backbone substitution. The origin of the 
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entropic change could be from changes in the folded state of the protein; however the crystal 
structures of proteins 5-7 closely matched that of wild-type GB1 and did not show elevated B 
factors in the areas around the β3-residues. An alternate explanation is that the β3-residues altered 
the solvation of the folded and unfolded protein states relative to 1. 
The denatured state of proteins is generally not an extended peptide chain but better 
described as a dynamic mixture of structures.171 The complexity of the denatured ensemble is 
challenging to probe experimentally, yet it is the reference state against which all folding 
thermodynamics of proteins are measured. We hypothesized that like most proteins,169 the 
unfolded state of GB1, minimizes solvent exposure of hydrophobic groups. In contrast, the 
additional conformational flexibility imparted by the β3-residues may raise the entropy of the 
protein backbone to a sufficient degree such that hydrophobic groups are exposed to solvent. 
This exposure of nonpolar surface area causes unfavorable ordering of water molecules into 
iceberg-like structures166, 169 around the hydrophobic groups. As the heterogeneous backbone 
folds, the nonpolar groups are buried and the ordered water is released, yielding a large favorable 
increase in solvent entropy that drives folding. Although the more flexible backbone of β3-
residues likely contributes unfavorably to the change in folding chain entropy in the protein, the 
large increase in solvent entropy upon folding significantly compensated any entropic penalty 
introduced into the protein backbone (Figure 51). 
The ΔCp° for protein folding is dependent on several factors including change in solvent 
accessible surface area (ΔASA), hydrogen bonding, conformational entropy, and residual 
structure in the denatured state.172 For many proteins, a negative change in heat capacity 
accompanies the folding transition.172 Wild-type 1 and each of the β3-containing mutants 
displayed a negative ΔCp° of approximately the same value suggesting that β3-residues do not 
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significantly alter the heat capacity of GB1 folding. This is somewhat surprising given the 
enthalpic and entropic contributions to ΔCp° and likely reflects the complex interplay of 
additional factors that contribute to heat capacity in proteins. 
 
 
 
Figure 51. Hypothesized differences between denatured ensembles of native and β3-containing 
proteins. Gray spheres represent hydrophobic side-chains. 
 
 
Like heat capacity, m, the sensitivity of the protein backbone to chemical denaturation, is 
dependent on the change in solvent accessible surface area. Changes in m can offer insight into 
differences to the complex denatured ensemble. In contrast to the observed changes to ΔCp°, m 
depended strongly on the secondary structure modified. While loop mutant 5 had an identical 
value of m as wild-type, α→β3 substitution in the helix of GB1 in either 6 or 7 led to a significant 
increase in denaturant sensitivity. One explanation could be that the β3-residues altered the 
change in ASA through increased backbone flexibility (Figure 51). The helix of wild-type GB1 
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may retain residual structure in the unfolded state as opposed to the more disordered loops which 
could explain the difference in m values observed for 5 and 6/7.  
3.1.2 β3→β2 Substitution 
In our work on sheet-based mimicry, we explored the use of both β3 and β2-residues as 
replacements for α-residues in model hairpin peptides.119-120 As regioisomers of β3-residues, β2-
residues have been studied primarily in β-peptides and found to promote helical structures in 
organic solvents, especially in combination with other classes of β-residues.48 Prior 
computational studies compared the conformational preferences of model β2 and β3-amino acids 
in explicit water.173 Comparison of the lowest energy structures for each residue type with 
dihedrals from the crystal structure of 6 suggested that β2-residues would be better 
accommodated in an α/β-helix. Using β3-helix mutant 6 as a starting point, we synthesized 
proteins 17-19 to examine the thermodynamic effects of β3→β2 substitution (Figure 52). 17 and 
18 explored the energetics of a single substitution, either an alanine (17) or asparagine (18) 
whereas the design of 19 replaces all four β3-residues with the β2-analogue.  
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Figure 52. Sequences of synthesized helix mutants 6 and 17-19 and biologically expressed 
mutant 20. Underlined residues indicate point mutations relative to synthesized wild-type 1. R is the side-
chain group of the corresponding α-residue. 
 
 
We speculated that one factor contributing to the enthalpic destabilization upon α→β3 
substitutions was the loss of backbone orbital interactions.174 Recent theoretical work 
investigated the relationship between hydrogen bonding or n→π* orbital interactions in 
proteins.175 In this study, the side-chain carbonyl oxygen of asparagine residues in numerous 
proteins was examined for its ability to participate in both forms of electron delocalization 
interactions. Inspired by this precedent, we hypothesized that unlike β3-Asn, the side-chain 
carbonyl oxygen of β2-Asn could engage in an intraresidue n→π* interaction (Figure 53). The 
single asparagine substitution in sequence 18 was designed to test for the presence and 
thermodynamic impact of an intraresidue side-chain to backbone n→π* interaction.  
 
 
 88 
 
Figure 53. Proposed intraresidue n→π* interaction possible in β2-Asn. 
 
 
Proteins 17 and 18 have a fold identical to that of 6 as shown in high-resolution crystal 
structures (Figure 54). In both 17 and 18, β2-residues did not elevate local B-factors in the helix 
region. The relative positions of the Cα and Cβ atoms of the β2-residues in the helices of 17 and 
18 matched those of the corresponding β3-analogues in 6. In two out of four copies of mutant 18 
from the crystal asymmetric unit, the side-chain carbonyl oxygen of β2-Asn appeared to engage 
in an intraresidue n→π* interaction, supporting our design hypothesis. The distance between the 
side-chain oxygen and the main chain carbonyl, however, was at the upper limit for a n→π* 
interaction (> 3 Å).174 
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Figure 54. A) Overlay of helices from crystal structures of 6 (yellow), 17 (green), and 18 (gray). 
B) Close-up of β3/β2Ala24 in 6 and 17. C) Close-up of β3/β2-Asn35 in 6 and 18. Dotted line highlights a 
putative intraresidue orbital interaction in β2-Asn35 that may contribute favorably to folded stability of 
protein. 
 
 
Overall, β2-residues did not significantly alter the free energy of folding relative to β3-
residues as revealed by fits of combined thermal and chemical denaturation of proteins 17-19 
(Figure 55). The enthalpy and entropy of folding for 17 and 18 were indistinguishable from that 
of the blueprint sequence 6. Changes in ΔG°fold were minimal except in the case of 19 where a 
1.6 kcal/mol destabilization was observed. We attributed this to modification of Lys31 in the 
center of the helix. The side-chain of Lys31 packs against the aromatic face of the indole ring 
from Trp43 from the sheet in the crystal structures of both wild-type GB1 and helix-modified 
analogue 6. (see Chapter 2). Moving the lysine side-chain to the β2-position would abolish this 
favorable interaction resulting in an enthalpic penalty. To discern the thermodynamic impact of 
losing this packing interaction of Lys31 with Trp43, we bacterially expressed a GB1 Lys31→Ala 
mutant (sequence 20). Point mutant 20 had a ΔΔG°fold of +1.0 kcal/mol relative to an expressed 
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wild-type GB1 protein, approximately the same energetic difference in folded stabilities between 
19 and 18. It is notable that replacement of Lys31 with Ala reduced the folded stability by 
approximately 20 % relative to the recombinant wild-type sequence (Table 10). 
Contrary to our hypothesis regarding a potential role of n→π* interactions, replacement of 
β3-Asn with a β2-analogue did not significantly alter the ΔH° of folding relative to 6. Relocation 
of the side-chain of β3-Asn35 to the Cα atom as in 18 resulted in a small (~ 0.5 kcal/mol) 
enthalpic stabilization towards folding. As observed in a subset of chains in the crystal structure 
of 18 (Figure 54), the side-chain of β2-Asn occupied a conformation suggestive of an intraresidue 
n→π* interaction, however, the distance between the participating atoms strongly diminishes the 
energetic stabilization towards folding. Any contribution of this transient interaction to the 
overall folded stability of the protein is at best marginal.  
Changes to ΔCp° and m for β2-mutants 17-19 were small relative to 6 (Figure 55, Table 
10), though some trends were observed. β3→β2 substitution slightly decreased both changes in 
heat capacity and m, suggesting possibly small alterations to the denatured ensemble. 
Collectively, the data suggested that β2-residues are isoenergetic relative to β3-residues and key 
side-chain interactions should guide the choice of one over the other for α-residue replacement in 
proteins.  
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Figure 55. Changes in thermodynamic parameters of folding for mutants 17-19 relative to 6.  
 
 
Table 10. Thermodynamic Parameters for the Folding Transitions of 6 and 17-19 at 298 K. 
# ΔH° (kcal mol-1) 
TΔS° 
(kcal mol-1) 
ΔG° 
(kcal mol-1) 
ΔCp° 
(kcal mol-1 K-1) 
m 
(kcal mol-1 M-1) 
ΔΔG° 
(kcal mol-1)a 
 
6 -18.3 ± 0.4 -15.2 ± 0.3 -3.1 ± 0.5 -0.53 ± 0.02 -2.48 ± 0.05 -  
17 -18.8 ± 0.5 -15.8 ± 0.3 -3.0 ± 0.5 -0.45 ± 0.02 -2.25 ± 0.05 +0.1 ± 0.8  
18 -18.7 ± 0.5 -16.1 ± 0.3 -2.6 ± 0.5 -0.48 ± 0.02 -2.36 ± 0.04 +0.5 ± 0.8  
19 -17.0 ± 0.4 -15.5 ± 0.3 -1.5 ± 0.5 -0.48 ± 0.02 -2.45 ± 0.04 +1.6 ± 0.8  
20 -22.7 ± 0.4  -18.5 ± 0.3 -4.2 ± 0.5 -0.67 ± 0.02 -1.77 ± 0.03  +1.0 ± 0.8b  
GB1c -23.0 ± 0.5 -17.9 ± 0.3 -5.1 ± 0.6 -0.57 ± 0.02 -1.71 ± 0.04 -  
a. Relative to 6. 
b. Relative to biologically expressed wild-type GB1. 
c. From recombinant expression in E. coli. 
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3.1.3 β3→βcyc Substitution 
The increased backbone flexibility of β3/β2-residues inspired prior experimental176-178 work to 
design β-residues that “prepay” the chain entropic cost towards folding. Backbone cyclization 
through the side-chain atoms led to βcyc-residues that were shown to promote helical folds in β-
peptides.176 In particular, (S,S)-ACPC was found to support α-helix-like folds in mixed α/β 
peptides.71, 110, 179 
βcyc-Residue containing GB1 analogues 21-24 were synthesized to quantify the 
thermodynamic impact of backbone cyclization of β-residues in the helix of GB1 (Figure 56). 
Sequences 21 and 22 replace either the outer or inner pair of β3-residues while 23 substitutes all 
four β3-residues with the βcyc-residue. To determine if there would be synergistic effects of 
multiple ACPC residues (X) as well as explore backbone cyclization in the loops of GB1, we 
replaced the final residue of each loop with residue X and grafted the most thermodynamically 
stable βcyc backbone sequence (vide infra) to generate combined loop/helix mutant 24. 
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Figure 56. Sequences of mutants 6 and 21-24. R is the side-chain group of the corresponding α-
residue. 
 
 
Crystal structures of 21 and 24 showed that β3→βcyc replacement did not alter the tertiary 
fold of 6 (Figure 57). The average dihedral of the central Cα-Cß (θ) bond of β3-residues in 6 (82 
°) closely matched that observed for ACPC previously179 and in 21 and 24 (86 °). Overlays of β3 
from 6 and βcyc-residues from either 21 or 24 at matching locations in the helix and loops showed 
identical relative positions of the Cα and Cß atoms.  
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Figure 57. A) Overlay of helices from crystal structures of 6 (yellow), 21 (green), and 24 (ivory). 
B) Close-up of helices in 6 and 21. C) Close-up of loop in 5 (orange) and 24. 
 
 
Relative to β3-residues, βcyc-residues did not appreciably alter the folding enthalpy except 
in cases where residues with charged side-chains (lysine) were replaced, akin to the observations 
of β3→β2 substitution (Figure 58, Table 11). As expected, fits of combined thermal and chemical 
melts of backbone cyclized mutants 21-24 showed a consistently lower ΔS° than all β3-mutant 6 
in accordance with design hypotheses. In cases where polar residues were replaced, the entropic 
stabilization afforded by backbone preorganization was surpassed by the enthalpic penalty of 
losing the polar contacts of Lys31. The combined loop/helix mutant 24 had a fold identical in 
stability to both 6 and 21. Accounting for the energetic penalty of introducing β3-residues into 
the loop of GB1 (~ 0.3 kcal/mol per replacement), the data suggested that β3→βcyc substitution in 
the loops was overall favorable towards folding.  
The ability of the βcyc-residues to preorganize the backbone was apparent from changes to 
ΔCp° and m. β3→βcyc replacement consistently decreased the change in heat capacity and m. 
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Cyclic residues were anticipated to promote structure even in the denatured state based on 
restricted backbone conformational freedom. Due to the dependence of both ΔCp° and m on 
ΔASA, this increase of residual structure would decrease the change in accessible surface area. 
This effect scaled with the number of βcyc-residues in the helix with mutant 23 having the 
smallest ΔCp° and m values.  
 
 
 
Figure 58. Changes in thermodynamic parameters of folding for mutants 21-24 relative to helix 
mutant 6. 
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Table 11. Thermodynamic Parameters for the Folding Transitions of 6 and 20-23 at 298 K. 
# ΔH° (kcal mol-1) 
TΔS° 
(kcal mol-1) 
ΔG° 
(kcal mol-1) 
ΔCp 
(kcal mol-1 K-1) 
m 
(kcal mol-1 M-1) 
ΔΔG° 
(kcal mol-1)a 
 
6 -18.3 ± 0.4 -15.2 ± 0.3 -3.1 ± 0.5 -0.53 ± 0.02 -2.48 ± 0.05 -  
21 -18.4 ± 0.5 -14.9 ± 0.3 -3.5 ± 0.6 -0.48 ± 0.02 -2.00 ± 0.05 -0.4 ± 0.8  
22 -16.3 ± 0.3 -14.3 ± 0.3 -2.0 ± 0.4 -0.49 ± 0.02 -1.76 ± 0.03 +1.1 ± 0.8  
23 -13.8 ± 0.3 -11.9 ± 0.3 -1.9 ± 0.4 -0.39 ± 0.02 -1.49 ± 0.03 +1.2 ± 0.8  
24 -18.2 ± 0.5 -14.9 ± 0.3 -3.3 ± 0.6 -0.52 ± 0.02 -1.71 ± 0.04 -0.2 ± 0.8  
a. Relative to 6. 
 
 
3.1.4 β3→Cα Methyl Substitution 
β-Residues can be thought of as backbone methylated analogues of α-residues where the 
additional methylene unit is inserted between the carbonyl carbon and Cα.. Cα-methyl residues 
are similarly backbone methylated analogues of α-amino acids but instead place the methylene 
group between Cα and Hα. The prototypical Cα-methyl residue Aib induces helical folding in 
peptides due to a restricted Ramachandran space where only helical conformations are 
significantly populated.180 Studies on replacement of alanine with Aib in a helical subdomain of 
thermolysin found that Aib enhanced the thermostability of the folded protein by ~3 kcal/mol on 
average.36 Oligomers of Aib are achiral and can equally adopt either left or right-handed 310 
helices, a naturally occurring and narrower type of helix.35 Incorporation of Aib into L-α-
peptides stabilizes a right-handed α-helical fold.35, 132 Efforts to engineer a right-handed 
preference into Aib have resulted in chiral Cα-methyl residues that show a strong preference 
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based on the stereochemical configuration.181 Prior work182-184 investigated the folding 
propensities of chiral L-Cα-methyl valine in the crystalline state and found a > 95 % preference 
for the right-handed helix.181 Despite their prevalent use in helix stabilization, few studies have 
examined the thermodynamic impact of Cα-methyl residue incorporation on peptide or protein 
folding.185-186 
Relative to β3-residues, Cα-methyl residues are regioisomers and are expected to be 
considerably more effective at helix stabilization and provide enhanced proteolytic protection.187 
Based on literature precedent, β3→Cα-methyl substitution in the helix of GB1 should be 
favorable towards folding. We designed and synthesized two Cα-methylated analogues of GB1 
(25 and 26, Figure 59). The design of 25 replaced the outer β3-residues of 6 with Aib. 26 retains 
the sequence of 25 but exchanges Aib for chiral Cα-methyl valines. We anticipated that both 25 
and 26 would have more stable folds than parent sequence 6.  
 
 
 
Figure 59. Sequences of Cα-methylated GB1 analogues 25 and 26. R is the side-chain group of 
the corresponding α-residue. 
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As predicted, Aib was well tolerated in the helix of GB1. 25 had a fold identical to that of 
6 (RMSD = 0.4 Å) as shown in the crystal structure (Figure 60). Side-chain positions of 25 
matched those of β3-mutant 6 and βcyc-mutant 21 even at locations substituted with Aib.  
 
 
 
Figure 60. A) Overlay of helices from 6 (yellow) and 25 (gray). B) Close-up of Ala/Aib24 in 
6/25. C) Close-up of ACPC/Aib35 in 21 (orange)/26. Aib residues are colored green in all structures. 
 
 
Combined thermal and chemical denaturation CD experiments of 25 and 26 supported the 
hypothesis that Cα-methyl residues promote helical folds. β3→Cα-Me substitution consistently 
stabilized protein folding (Figure 61, Table 12). Relative to mutant 6, Cα-methylation was 
enthalpically favorable and entropically unfavorable towards folding. The magnitude of the 
changes to ΔH° and ΔS° was much greater (>2x) for replacement of a β3-residue with Aib than 
the corresponding substitution with Cα-Me-Val. Both Aib and Cα-Me-Val do not have an 
extended backbone relative to α-residues as opposed to βcyc-residues. This feature of 25 and 26 
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should retain any native enthalpically favorable towards folding orbital interactions and may 
explain the observed differences in ΔH°. It may be that the bulky isopropyl side-chain of Cα-
methylated valine introduced steric clashes and/or required significantly more solvation in the 
folded state. Although βcyc-residues were slightly more entropically favorable towards folding, 
the enthalpic folding stabilization afforded by Cα-methylation overcompensated for their reduced 
entropic benefit towards folding. The entropic penalty toward folding of Aib incorporation was 
larger than that of Cα-methyl valine. The lack of chiral preference in Aib may have increased the 
entropy of the unfolded state. 
Introduction of Cα-methyl residues did not significantly alter ΔCp° but did reduce m 
relative to 6. This trend was observed for β3→βcyc replacement and was attributed to a reduction 
in ΔASA due to backbone preorganization. In this context, restricted backbone dihedral angles 
likely promoted folded structure, even in the unfolded state. The extent of reduction in m values 
compared to 6 was greater for Cα-methyl residues than βcyc-residues suggesting a higher degree 
of residual structure and/or a less exposed nonpolar surface in the denatured ensemble. 26 had a 
larger value of m likely due to the exposure of bulky isopropyl groups in the folded state which 
increased the ΔASA. 
 
 
 100 
 
Figure 61. Changes in thermodynamic parameters of folding for mutants 21, 25, and 26 relative 
to helix mutant 6. 
 
 
Table 12. Thermodynamics of Folding for Proteins 6, 21, 25, and 26 at 298 K. 
# ΔH° (kcal mol-1) 
TΔS° 
(kcal mol-1) 
ΔG° 
(kcal mol-1) 
ΔCp 
(kcal mol-1 K-1) 
m 
(kcal mol-1 M-1) 
ΔΔG° 
(kcal mol-1)a 
 
6 -18.3 ± 0.4 -15.2 ± 0.3 -3.1 ± 0.5 -0.53 ± 0.02 -2.48 ± 0.05 -  
21 -18.4 ± 0.5 -14.9 ± 0.3 -3.5 ± 0.6 -0.48 ± 0.02 -2.00 ± 0.05 -0.4 ± 0.8  
25 -22.7 ± 0.6 -17.9 ± 0.3 -4.8 ± 0.5 -0.48 ± 0.02 -1.57 ± 0.03 -1.7 ± 0.8  
26 -19.9 ± 0.4 -15.8 ± 0.3 -4.1 ± 0.5 -0.46 ± 0.02 -1.72 ± 0.04 -1.0 ± 0.7  
a. Relative to 6. 
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3.2 CONCLUSIONS 
Our dataset on the thermodynamics of protein-like oligomers with unnatural backbones revealed 
several interesting insights. Relative to the wild-type sequence, β3-residues were enthalpically 
destabilizing towards folding when inserted into either the loops or helix of GB1. Based on the 
increase in backbone conformational freedom, α→β3 substitution was expected to increase the 
entropic penalty towards folding in a protein. Instead, incorporation of β3-residues was 
entropically favorable towards folding. Based on observed changes to ΔCp° and m, we attributed 
this effect to altered solvation of the unnatural backbone in the denatured ensemble. The entropic 
stabilization of α→β3 replacement was always outweighed by a larger enthalpic penalty towards 
folding. 
We used a mutant of GB1 bearing β3-residues in the helix as a reference for further 
backbone modifications. Introduction of β2-residues into the helix of GB1 was overall 
isoenergetic relative to a β3-analogue. Replacement of all four β3-residues led to a mutant with ~ 
1.5 kcal/mol less folded stability. The loss of a favorable tertiary interaction due to the 
translocation of a side-chain compensated for any differences in folding free energies between β3 
and β2-residues. In designing unnatural oligomers, both classes of β-residues may be used, 
however, key side-chain interactions should guide the choice of one regioisomer over another. In 
this aspect, GB1 may not have been the best system to examine the thermodynamic effect of 
β3→β2 substitutions. One other important consideration is the ease of monomer synthesis. Many 
β3-residues bearing natural side-chains are commercially available. In contrast, the preparation of 
protected β2-analogues of polar or charged amino acids is nontrivial and requires multi-step 
syntheses.188 
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Cyclization of the β-residue is thought to prepay the entropic cost towards arranging the 
backbone into a folded conformation. Replacement of β3 residues with βcyc-residues was at best 
energetically neutral. β3→βcyc substitution was entropically favorable to folding beyond that 
observed for β3-residues. However, replacement of side-chains involved in tertiary interactions 
resulted in steep enthalpic folding penalties that yielded a net loss of folded stability. Our data 
suggested that βcyc residues promote structure in the denatured ensemble as the physical basis for 
the favorable ΔS°. While βcyc-residues may alter solvation of the backbone like β3-residues, this 
is likely a minor contribution to the observed entropic stabilization toward folding. 
As an alternate to β-residues, Cα-methyl residues were expected to strongly promote 
helical folds based on restricted accessible dihedral angles. Structural and biophysical 
characterization of two distinct Cα-methylated GB1 mutants revealed highly stable tertiary folds. 
In both mutants, β3→Cα-Me substitution was enthalpically favorable towards folding. Compared 
to β-residues, Cα-methyl residues have one fewer backbone atom. The lengthened backbone of β-
residues precludes their participation as acceptors for n→π* interactions, which may explain the 
more favorable folding enthalpies of the Cα-methyl GB1 mutants. The ΔH of helices containing 
Aib was found to be significantly greater than those with Cα-methyl valine. The larger isopropyl 
chain of Cα-methyl valine relative to a methyl group of Aib could introduce steric clashes with 
backbone and/or side-chain atoms in the folded state and result in enthalpic penalties towards 
folding. 
Several trends were observed for the ΔΔSfold relative to β3-residues. Both βcyc and Cα-
methyl residues are expected to reduce the conformational freedom of the denatured ensemble 
and provide an entropic driving force towards folding. βcyc-residues introduced a favorable 
entropic stabilization towards folding in GB1, yet analogous mutants containing Cα-methyl 
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residues were entropically unfavorable towards folding. The restricted backbone dihedrals of Cα-
methyl residues should promote helical structure in a similar manner to backbone cyclization of 
β-residues, however, there are clearly other contributing factors to the folding entropy of 
proteins. The smaller m values for Cα-methyl-residues compared to βcyc-residues suggest that the 
former are stronger promoters of α-helical structure in both unfolded and folded states. It has 
been previously observed that Cα-methylation reduces the configurational entropy of folded state 
when incorporated at flexible regions in a native protein structure.36 A similar reduction in the 
entropy of the folded of GB1 may have resulted from Cα-methylation near the termini of the 
helix. 
 
 
Table 13. Proposed Physical Bases for Observed Thermodynamic Changes to Folding Enthalpy 
and Entropy in Backbone-Modified GB1 Mutants Relative to α-Residues 
 Acyclic 
β-Residues 
βcyc-Residues Cα-Me Alanine 
(Aib) 
Cα-Me Valine 
Observed 
Changes to 
 
 
  
ΔHfold 
+ retains side-chain 
 
+ promotes helical fold + promotes helical 
fold  
 
+ promotes helical 
fold  
 
- lengthens 
backbone 
(loss of orbital 
interactions) 
- loss of side-chain 
- lengthens backbone 
 
 - may introduce 
steric clashes 
ΔSfold 
+ altered solvation + altered solvation 
+ preorganized 
backbone 
+ chiral 
+ preorganized 
backbone 
+ preorganized 
backbone 
+ chiral 
- flexible backbone  - achiral  
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In every thermodynamic dataset obtained, changes to folding enthalpy were at least 
partially offset by changes to folding entropy. This trend has been observed in several other 
protein systems and has been referred to as enthalpy-entropy compensation (EEC).189-191 
Although EEC in protein folding is a highly controversial subject, it is noteworthy that 
heterogeneous backbone oligomers that have tertiary folds also share this feature of natural 
proteins. 
Future endeavors will include the use of unnatural residues to stabilize protein folds 
comparable to or better than that of α-amino acids. The design of such residues will utilize the 
wealth of information on the thermodynamics of folding of proteins with unnatural backbones 
shown in this chapter. In particular, investigations of the effects of Cα-methylation of polar or 
charged α-amino acids on protein folding will add to our thermodynamic dataset. Combining 
second generation helix, loop, sheet, and turn substitution strategies and measuring the changes 
to folding thermodynamics as well as proteolytic resistance will enhance the current field of 
protein mimetics. Application of the strategies developed here to other, more complex targets 
will enable a test of the robustness of the backbone modification methods. 
3.3 EXPERIMENTAL 
3.3.1 General Information 
Solvents and all other reagents were purchased from Aldrich, Baker, EMD, or Fisher and used 
without further purification. HOBt was purchased from Anaspec Inc. HCTU, NovaPEG Rink 
Amide Resin, and Fmoc-protected α-amino acids were purchased from Novabiochem. Fmoc-
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protected β-amino acids were purchased from Aapptec. Flash column chromatography was 
performed using Silicycle SiliaFlash P60 (230-400 mesh) silica gel. Optical rotations were 
measured on a Perkin-Elmer 241 digital polarimeter with a sodium lamp at ambient temperature. 
NMR spectra were recorded on a Bruker Advance 400 spectrometer.  
3.3.2 Synthesis of Fmoc-β2-Asn(Dmcp)-OH 
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Scheme 3.1 Synthesis of Fmoc-β2-Asn(Dmcp)-OH 
 
 
Ethyl (1S, 5R)-2-oxo-3-oxabicyclo [3.1.0] hexane-1-carboxylate (27): Compound 
27 was synthesized according to a published protocol.192 Sodium (1.15 g, 50 mmol) 
O
OOO
27
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was dissolved in ethanol (115 mL) under a N2 atmosphere. The solution was cooled in an ice 
bath and diethyl malonate (9.2 mL, 60 mmol) was slowly added. After 10 minutes, R-
epichlorohydrin (4.0 mL, 50 mmol) was slowly added over 20 minutes. The solution was 
refluxed overnight and concentrated. The residue was dissolved in water (100 mL) and the 
aqueous solution was extracted three times with 100 mL DCM. The organic layers were 
combined, dried with magnesium sulfate and concentrated. The concentrate was purified using 
FCC (20 % ethyl acetate in hexanes) to afford the product as a colorless oil (4.4 g, 26 mmol, 52 
% yield). NMR data agreed with previously reported results.192  
 
 
Ethyl (3S,4S)-4-(azidomethyl)-2-oxotetrahydrofuran-3-carboxylate (28): 
Compound 28 was synthesized according to a published protocol.192 A solution of 
27 (4.4 g, 26 mmol), sodium azide (6.7 g, 104 mmol), glacial acetic acid (5.9 mL, 
104 mmol), and TEA (72 µL, 0.5 mmol) in anhydrous DMF (100 mL) was heated 
at 70 °C for 4 h under a N2 atmosphere. The DMF was removed under reduced pressure and 200 
mL saturated ammonium chloride solution was added. The aqueous solution was extracted three 
times with 200 mL DCM. The organic layers were washed three times with 100 mL saturated 
ammonium chloride, dried with magnesium sulfate, and concentrated to give the product as a 
colorless oil (3.9 g, 18.4 mmol, 71 % yield). NMR data agreed with previously published 
results.192 
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(S)-4-(azidomethyl) dihydrofuran-2(3H)-one (29): Compound 29 was 
synthesized according to a published protocol.193 A solution of 28 (3.9 g, 18.4 
mmol) and p-toluenesulfonic acid monohydrate (14.0 g, 74 mmol) in DMSO was 
heated at 120 °C overnight. The reaction was cooled and 200 mL water was added. The solution 
was extracted four times with 200 mL ethyl acetate. The organic layers were washed three times 
with 100 mL saturated ammonium chloride, dried with magnesium sulfate, and concentrated to 
give the product as a colorless oil (1.5 g, 10.6 mmol, 57 % yield). NMR data agreed with 
previously published results.193 
 
 
(S)-4-azido-N-(2-cyclopropylpropan-2-yl)-3-(hydroxymethyl) 
butanamide (30): To a solution of aluminum chloride (3.1 g, 23.3 mmol) 
suspended in anhydrous DCM (100 mL) cooled on ice under a N2 
atmosphere was added TEA (6.5 mL, 47 mmol). The solution was stirred for 15 minutes before 
29 (1.5 g, 10.6 mmol) and α,α-dimethyl-cyclopropylmethanamine p-toluenesulfonic acid (3.2 g, 
11.7 mmol) were added. The solution was stirred overnight at ambient temperature and 
concentrated. The residue was dissolved in 200 mL ethyl acetate and washed twice with 100 mL 
5% sodium bicarbonate solution, once with 100 mL saturated ammonium chloride, and once 
with 100 mL brine. The organic layers were dried with magnesium sulfate and concentrated to 
afford the product as a colorless oil (1.6 g, 6.7 mmol, 63 % yield). [α]20= -7.1 (c = 1.1 in CHCl3). 
1H NMR (400 MHz, CDCl3) δ 5.67 (s, 1 H), 3.71 (m, 2 H), 3.47 (m, 2 H), 2.25 (m, 3 H), 1.28 
(m, 8 H), 0.43 (m, 4 H). 13C NMR (100 MHz, CDCl3) δ 170.0, 62.6, 52.9, 51.5, 37.1, 36.7, 23.0, 
20.4, 0.0. HRMS m/z calculated for C11H21N4O2 (M+H)+ 241.1659; found 241.1660.  
O
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(9H-fluoren-9-yl) methyl-(S)-(4-((2-cyclopropylpropan-2-yl) 
amino)-2-(hydroxymethyl)-4-oxobutyl) carbamate (31): A 
solution of 30 (1.6 g, 6.7 mmol), palladium hydroxide on carbon (0.3 
g), and palladium on carbon (0.3 g) in MeOH (75 mL) was stirred for 
two days under a H2 atmosphere. The reaction was filtered through Celite with MeOH and 
concentrated to afford the amino alcohol which was carried forward without further purification. 
To a solution of the amino alcohol in DCM (50 mL) was added FmocOSu (2.5 g, 7.4 mmol) and 
DIEA (4.8 mL, 27 mmol). The reaction was stirred for 4 h and concentrated. The residue was 
dissolved in 100 mL ethyl acetate, washed with 30 mL 5% sodium bisulfate, dried with 
magnesium sulfate, and concentrated. FCC (50 % ethyl acetate in hexanes) afforded the product 
as a white solid (1.5 g, 3.4 mmol, 50% yield). [α]20= +1.25 (c = 0.8 in CHCl3). 1H NMR (400 
MHz, DMSO-d6) δ 7.90 (d, J = 8 Hz, 2 H), 7.70 (d, J = 8 Hz, 2 H), 7.43 (t, J = 4 Hz, 2 H), 7.34 
(t, J = 4 Hz, 2 H), 7.28 (s, 1 H), 7.23 (t, J = 4 Hz, 1 H), 4.46 (t, J = 4 Hz, 1 H), 4.30, (m, 3 H), 
3.30 (m, 2 H), 3.00 (m, 2 H), 2.01 (m, 3 H), 1.27 (m, 1 H), 1.15 (s, 6 H), 0.28 (m, 4 H). 13C NMR 
(100 MHz, DMSO-d6) δ 169.9, 155.3, 142.8, 139.6, 126.5, 125.9, 124.1, 119.0, 64.0, 60.5, 51.2, 
45.6, 40.1, 35.2, 23.6, 19.4, 0.0. HRMS m/z calculated for C26H33N2O4 (M+H)+ 437.2440; found 
437.2427. 
 
 
Fmoc-(S)-β2-Asn(Dmcp)-OH (32): To a stirred solution of sodium 
dichromate in water (1 M) was added concentrated sulfuric acid to a 
H
N OH
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O
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final concentration of 4 M. The solution was then diluted with water to a final concentration of 
0.5 M sodium dichromate and 2 M sulfuric acid. To a solution of 31 (2.2 g, 5.0 mmol) in acetone 
(78 mL) was added Jones reagent (12.5 mL). After 2.5 h, 20 mL isopropanol was added and the 
solution was stirred for 30 minutes. The reaction was diluted with 400 mL ethyl acetate, washed 
once with 200 mL 5 % sodium bisulfate, twice with 200 mL brine, dried with magnesium 
sulfate, and concentrated. The residue was purified by FCC (dry-loaded in 1 % TEA 50 % ethyl 
acetate in hexanes, eluted with 1 % acetic acid in ethyl acetate) to afford the product as a white 
solid (0.58 g, 1.3 mmol, 26 % yield). [α]20= -28.8 (c = 1.0 in CHCl3). 1H NMR (400 MHz, 
DMSO-d6) δ 7.87 (d, J = 8 Hz, 2 H), 7.68 (d, J = 8 Hz, 2 H), 7.41 (t, J = 4 Hz, 2 H), 7.34 (t, J = 4 
Hz, 2 H), 4.23 (m, 3 H), 3.19 (m, 2 H), 2.80 (m, 1 H), 2.22 (m, 2 H), 1.15 (m, 7 H), 0.26 (m, 4 
H). 13C NMR (100 MHz, DMSO-d6) δ 175.2, 170.3, 156.6, 144.4, 144.3, 141.2, 128.1, 127.5, 
125.7, 120.6, 65.9, 52.8, 47.2, 42.4, 42.3, 36.1, 25.3, 25.2, 21.1, 1.64, 1.56. HRMS m/z 
calculated for C26H29N2O5 (M-H)- 449.2071; found 449.2081. 
 
3.3.3 Protein Synthesis and Purification 
Proteins 17-19, 21-26 were synthesized using the automated synthesis protocol described in 
Section 2.5.2. Mutant 20 and a wild-type GB1 analogue were biologically expressed following 
published protocols194 using a GB1 plasmid graciously provided by Timothy F. Cunningham and 
Sunil Saxena (University of Pittsburgh). Proteins were cleaved as described in Section 2.5.2. All 
proteins were purified by reversed-phase HPLC as described in Section 2.5.3. 
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Figure 62. Analytical HPLC chromatograms of purified proteins 17-26. 
 
 
Table 14. MALDI-TOF MS Data for Proteins 17-24. 
# [M+H]
+ m/z (average) 
Calculated Observed 
17 6235.8 6232.6 
18 6235.8 6233.4 
19 6235.8 6234.8 
20 6164.7 6164.7 
21 6244.8 6241.0 
22 6173.6 6169.2 
23 6182.7 6179.6 
24 6252.9 6247.7 
25 6191.7 6191.9 
26 6247.8 6247.5 
 
 
3.3.4 Circular Dichroism 
CD measurements were performed on an Olis DSM17 Circular Dichroism Spectrometer in 1 mm 
quartz cells. Samples consisted of 40 µM protein in 20 mM sodium phosphate buffer, pH 7 with 
varying concentrations of guanidinium hydrochloride. Thermal melts were monitored at 220 nm 
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over the range of 4 °C to 98 °C with 2 °C increments, a dead band of 0.5 °C, and a 2 min 
equilibration time at each temperature. All measurements were baseline corrected for buffer. 
Raw CD data were fit using Mathematica 8 (Wolfram) and equations reported previously,167 
summarized briefly below. The protein folding free energy (ΔG) at a given temperature (T) and 
concentration of guanidinium ([Gdm]) is given by Equation 3.1: 
 
Equation 3.1 
 
where ΔH° and ΔS° are the folding enthalpy and entropy at a reference temperature T°, ΔCp the 
change in heat capacity, and m the dependence of the folding free energy on [Gdm]. The 
observed ellipticity (θobs) at a particular T and [Gdm] is given by Equation 3.2: 
 
Equation 3.2 
 
 
where θn and θu are the ellipticity of the folded and unfolded states. Based on literature 
precedent167-168 and inspection of the raw data, θn and θu were assumed to vary linearly with T 
and [Gdm] according to Equations 3.3 and 3.4: 
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Equation 3.3 
 
 
Equation 3.4 
 
 
Some proteins (5-7, 19, and 22-23) lacked well-defined fully folded baselines as a function of 
[Gdm]. The parameter f was constrained to zero for these fits; this approximation did not change 
the observed thermodynamic values by more than 10% when applied to proteins with better 
defined baselines.168 The folding/unfolding transitions of GB1 and its analogues were assumed to 
follow a two-state model,95 and it was assumed that ΔCp and m do not vary over the range of 
experimental conditions. 
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Figure 63. Fits of combined thermal and chemical melts of proteins 1, 5-7, 17-26. 
 
 
3.3.5 Crystallization of Proteins 
Diffraction quality crystals of proteins 17, 18, 21, 24, and 25 were obtained by the hanging drop 
vapor diffusion method as described in Section 2.5.8 using ~15 mg/mL solutions of protein in 
water. Table 15 summarizes the buffers for each protein. 
 
 
Table 15. Crystallization Conditions for Proteins 17, 18, 21, 24, and 25.  
Protein Buffer Precipitant(s) 
17 200 mM NaOAc ph 4.6 20 % PEG 4000 
18 100 mM Na Cacodylate pH 6.5 0.15 M (MgOAc)2, 20% PEG 4000 
21 100 mM Na Citrate pH 5.6 20% isopropanol, 20% PEG 4000 
24 100 mM HEPES pH 7.5 0.2 M MgCl2, 30% isopropanol 
25 100 mM NaOAc pH 4.5 0.2 M (NH4)2SO4, 20 % PEG 4000 
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Data collection and structure refinement were performed by W. Seth Horne and Nathan 
Tavenor. Data collection methods used were identical to those described in Section 2.5.8 except 
for protein 18 which used a RAXIS HTC image plate. Analysis of the diffraction data with 
Xtriage in the Phenix software suite suggested that the structure of 18 showed evidence of 
twinning. The final structure was solved with twin law operators (H, -K, -L) with a twin fraction 
of 0.27. 
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Table 16. X-ray Diffraction Data and Refinement Statistics for Proteins 17, 18, 21, 24, and 25. 
# 17 18 21 (4OZB) 24 (4OZC) 25 
Data Collection      
Unit cell dimensions 
(Å, °) 
a  = 92.8, b = 22.4  
c = 65.3 
α = γ = 90, β = 134.1,  
 
a =b = 51.9, 
c = 96.4 
α = β = γ = 90 
a = b = 65.9, 
c = 21.9 
α = β  = γ = 
90 
a = b = 83.8, c = 
97.5 
α = β = γ = 90 
a = 74.4, b = 73.4, 
c= 79.4 
α = γ = 90, β = 99.4 
Space group C2 P41 I41 I4122 C2 
Resolution (Å) 23.44-1.95 (2.02–1.95) 
51.95-1.80 
(1.86-1.80) 
23.31-2.20 
(2.28-2.20) 
23.28–2.00  
(2.07–2.00) 
41.5-2.15 
(2.23-2.15) 
Total observations 34,719 297,770 13,203 166,708 260,925 
Unique observations 7,188 22,477 2,418 12,054 22,880 
Redundancy 4.8 (3.2) 13.25 (13.18) 5.46 (5.42) 13.83 (13.81) 11.40 (3.04) 
Completeness (%) 97.8 (90.4) 95.0 96.6 (98.8) 100 (100) 99.2 (93.2) 
I/σ 18.5 (3.6) 25.3 (4.9) 11.0 (3.2) 16.7 (4.5) 15.9 (4.2) 
Rmerge (%) 6.9 (15.2) 6.6 (40.5) 10.2 (26.4) 7.6 (39.6) 13.7 (23.9) 
Refinement      
Resolution (Å) 23.44–1.95 51.95-1.80 23.31-2.20 23.28–2.00 41.15-2.15 
R (%) 19.9 19.9 23.3 19.8 21.7 
Rfree (%) 23.0 21.7 26.0 21.0 25.2 
Avg. B factor (Å2) 22.1 27.3 38.1 39.4 25.5 
RMSD      
Bonds (Å) 0.005 0.006 0.007 0.007 0.005 
Angles (°) 1.04 1.13 1.14 1.05 1.02 
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4.0  IMPROVEMENTS TO SHEET MIMICRY STRATEGIES 
The results in this chapter have been published in: 
G.A. Lengyel, Z.E. Reinert, B.D. Griffith, W.S. Horne. "Comparison of backbone 
modification in protein β-sheets by α→γ residue replacement and α-residue methylation." 
Organic & Biomolecular Chemistry. 2014, 12, 5375-5381.  
 
All Fmoc-protected γ-residues were synthesized by George Lengyel. Synthesis of N-methyl 
GB1m2A mutants was performed by Brian Griffith. Analysis of 2D-NMR data was performed 
with Brian Griffith and George Lengyel. Synthesis and purification of GB1 mutants with γ-
residues was performed by George Lengyel. 
 
In Chapter 2, it was observed that N-methyl residues are tolerated in the sheets of GB1 with a 
small penalty towards folding. The following work details experiments probing the source of this 
destabilization in a model hairpin sequence as well as employing second generation sheet 
mimicry strategies in the full-length protein. 
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4.1 N-METHYL MODEL HAIRPIN INVESTIGATIONS 
Our work in sheet mimicry with unnatural backbones yielded several insights into our first 
generation design strategies. Mixed α/β backbones can form hairpins in aqueous solution in 
small oligomers but are prohibitively destabilizing towards folding to be used in a larger sheet 
system such as the tertiary fold of GB1. As a more conservative approach, we replaced one 
residue in each of the outer strands of GB1 with an N-methyl analogue. The resulting mutant had 
a folded stability near that of wild-type (∆∆G°fold = 1.0 kcal/mol). Given the subtle backbone 
modification relative to the parent sequence, we were surprised by the observed energetic 
penalty.  
To probe the small destabilization to folding resulting from incorporation of N-methyl 
residues, we used a model hairpin sequence derived from the C-terminal strands of GB1 referred 
to as GB1m2A120 (33) to design several sequences exploring N-methyl substitution (34-37, 
Figure 64). In each modified sequence, one of four residues bearing a nonpolar side-chain was 
replaced with an N-methyl analogue. These four side-chains form the hydrophobic core that 
helps to stabilize the hairpin fold of 33. We reasoned that any small changes introduced by N-
methylation would be most apparent at these positions. Importantly, these four positions also do 
not participate in any interstrand backbone N-H hydrogen bonds in the folded state that would be 
abolished by the modifications. 
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Figure 64. Sequences of model hairpin 33 and N-methyl mutants 34-37. An NMR solution 
structure of GB1m2A120 with the key hydrophobic core residues colored purple is shown on the right. 
 
 
Compared to GB1, model hairpin 33 possessed two main advantages that made it 
amenable to the current study. First, the sequence of GB1m2A is much shorter than that of the 
parent protein GB1 and chemical synthesis requires less time and material investment. Second, 
changes to the stability of the hairpin fold of 33 are readily quantified by 2D NMR analysis.120 
Finally, N-methyl residues are known to exhibit cis/trans isomerization about tertiary amides in 
solution.195 The cis and trans amide conformations of N-methylated residues in peptides 33-37 
should be distinguishable by 2D NMR methods.  
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Figure 65. Rationale of trans amide identification based on NOE contacts observed in 2D NMR 
experiments. Black arrows indicate key observed NOE contacts. 
 
 
We performed 1H homonuclear COSY, TOCSY, and NOESY experiments on peptides 
33-37 to examine the effect of N-methylation on the backbone of 33 (Table 17). We gauged the 
changes to folded populations through differences in Gly Hα/Hα´ proton chemical shifts, a well-
established method in hairpin-forming sequences.120 As observed in the larger sheet system of 
GB1, N-methyl substitution repeatedly destabilized the hairpin fold of 33. The ratio of cis:trans 
amide conformers was assigned through integration of a well resolved Asn6 TOCSY peak. The 
cis/trans isomerization of the tertiary amides complicated the interpretation of the NMR spectra 
of each backbone-modified mutant. We assigned the trans isomer based on analysis of the 
NOESY spectra, which revealed contacts between the backbone N-methyl group and side-chain 
and Hα protons of the preceding residue (Figure 65).  
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Figure 66. Cartoon of how a cis amide could severely destabilize a hairpin fold by displacing a 
critical hydrophobic side-chain from the core.  
 
 
The position of backbone N-methylation affected the folded populations of the trans 
isomer (Table 17). The presence of an N-methyl trans amide at either of the outer positions (34 
and 37) did not appreciably alter the folded population relative to 33. In contrast, N-methyl 
substitution closer to the β-turn led to considerably destabilized (~0.8 kcal/mol) hairpins. The cis 
amide at any of the four positions consistently showed very small differences in Gly Hα/Hα´ 
chemical shifts corresponding to a highly destabilized fold. This observation is reasonable given 
the probable outcome with respect to folding of a cis amide bearing a critical core hydrophobic 
side-chain (Figure 66). What is perhaps less obvious is why the trans amides near the center of 
the hairpin in peptides 35 and 36 had significantly smaller folded populations relative to the 
model hairpin.  
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Table 17. Folding Thermodynamics of Hairpin Peptides 33-37 from NMR Measurements.a 
# 
∆δ Gly10 
Hα/Hα´ 
(ppm) 
Fraction 
Folded (%) 
∆Gfold 
(kcal/mol) 
∆∆Gfold vs 33 
(kcal/mol) 
33 0.20 65 -0.3 - 
34b  37 +0.3 +0.6 
34trans (60 %) 0.19 61 -0.3 +0.0 
34cis (40 %) 0.09    
35b  19 +0.8 +1.1 
35trans (76 %) 0.09 30 +0.5 +0.8 
35cis (24 %) 0.00    
36b  29 +0.5 +0.8 
36trans (65 %) 0.12 38 +0.3 +0.6 
36cis (35 %) 0.00    
37b  55 -0.1 +0.2 
37trans (87 %) 0.20 63 -0.3 +0.0 
37cis (13 %) 0.12    
 
a. NMR carried out at 5 °C in pH 6.3 phosphate buffer. Assuming a 0.01 ppm uncertainty in 
measured Gly Hα/Hα´ separation, error propagation estimates uncertainties of 5 % for fraction folded and 
0.2 kcal/mol for ∆Gfold and ∆∆Gfold. 
b. Overall folded population calculated as product of the fraction of peptide in the trans amide 
configuration and fraction folded for trans isomer.  
 
 
Prior computational work has shown that N-methyl residues have less backbone 
conformational freedom than α-residues.196 Specifically, one region of the Ramachandran plot 
that becomes less energetically favorable corresponds to conformations typical of strands in an 
antiparallel β-sheet.197 This observation likely explains the somewhat destabilized trans amide 
hairpins of 35, 36, and GB1 sheet mutant 10. Further supporting this rationale is the marked 
unfavorable incorporation of N-methylation of residues near the turn of 33. Due to the restricted 
backbone space of N-methyl residues, the increased configurational freedom required of turn 
segments resulted in a larger energetic penalty towards backbone modification than the outer 
positions. 
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4.2 SECOND GENERATION GB1 SHEET MUTANTS 
As demonstrated earlier in Chapter 2, model hairpin sequence 33 has served as the basis of 
comparison for several backbone modification strategies including α→β119-120 and α→N-Me-α 
substitutions. Prior work in our lab examined an alternate design using a γcyc-residue derived 
from cis-3-aminocyclohexane carobxyclic acid (ACC).198 When incorporated into the sequence 
of 33, the resulting mutant retained the hairpin fold of the parent sequence (38, Figure 67). 
Despite the increased backbone length, the γcyc-modified hairpin had a larger folded population 
(83 %) than the all α-peptide 33 (67 %).198 
 
 
 
Figure 67. Sequences of GB1m2A hairpin 33 and mutants 38 and 39 with NMR solution 
structures of 33 (gray) and 38 (yellow) overlaid. Data from reference 198. 
 
 
Inspired by the success of γcyc-residues for sheet mimicry in hairpin, we looked to apply 
this strategy in the tertiary fold of GB1. However, the side-chains in larger proteins are often 
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involved in critical interactions necessary to stabilize the folded state. In prior work, a model 
peptide containing two α, β-unsaturated γ-residues bearing a side-chain at Cγ (referred to as a γ4-
residue) was shown to adopt a hairpin fold in organic solvent.199-200 We designed and synthesized 
a mutant of GB1m2A with two α→ γ4 substitutions to explore the ability of this residue type to 
promote hairpin folds in aqueous solutions (39, Figure 67).  
 
 
Table 18. Folding Thermodynamics of Hairpin Peptides 33, 38, and 39 from NMR 
Measurements.a 
# 
∆δ Gly10 
Hα/Hα´ 
(ppm) 
Fraction 
Folded (%) 
∆Gfold 
(kcal/mol) 
∆∆Gfold vs 33 
(kcal/mol) 
33 0.20 65 -0.3 - 
38b 0.26 83 -0.9 -0.6 
39 0.12 39 +0.2 +0.5 
a. NMR carried out at 5 °C in pH 6.3 phosphate buffer. Assuming a 0.01 ppm uncertainty in 
measured Gly Hα/Hα´ separation, error propagation estimates uncertainties of 5 % for fraction folded and 
0.2 kcal/mol for ∆Gfold and ∆∆Gfold. 
b. Data from reference 198. 
 
 
The folding propensity of 39 was characterized by 2D NMR experiments analogous to 
those used for N-methyl mutants 34-37 (Table 18). Whereas the γcyc-residues stabilized the 
hairpin fold, γ4-mutant 39 destabilized the sequence-encoded fold of GB1m2A by an equal 
amount (0.6 kcal/mol). Due to the low folded population of 39, we prepared a mutant bearing a 
Cys residue at each terminus (39cyc) to use for NMR solution structure determination. When the 
two terminial thiols are oxidized, the resulting disulfide stabilizes a hairpin fold. 39cyc formed a 
hairpin very similar to that of 33 (Figure 68). A comparison of the structures of γcyc and γ4-
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residues suggested that the additional rotatable bond present in the acyclic γ-residue likely 
accounts for the difference in observed folded populations of peptides 38 and 39. 
 
 
 
Figure 68. Solution structure of 39cyc from NMR analyses. γ4-Residues are colored pink. 
 
 
Having shown that γ-residues are tolerated in model hairpin systems, we applied our γcyc 
and γ4-based design strategies to the sheet of GB1 (40 and 41, Figure 69). Four α-residues in the 
sheet of GB1 were replaced with the corresponding γ4-analogue in 40 or an ACC-derived γcyc-
residue (X) in 41. To discern the thermodynamic cost toward folding of replacing polar residues 
in the sheet of GB1 with a hydrophobic γcyc-residue from any changes to the backbone of the 
protein we synthesized a point mutant of GB1 (42) that has three polar residues in the sheet 
replaced with nonpolar α-residues.  
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Figure 69. Sequences of wild-type 1, N-methyl sheet mutant 10, and sheet mutants 40-42. 
Underlined residues indicate side-chain changes relative to 1. 
 
 
CD scans of 40 and 41 suggested that both the vinylogous γ4 and γcyc-residues had an 
altered fold relative to GB1 (Figure 70). In particular, 40 had a CD spectrum that differed 
significantly in magnitude and shape compared to the other mutants and the wild-type protein. 
However, as seen in earlier work (Chapter 2), changes in CD scans from unnatural backbone 
modifications do not necessarily correlate with alterations in folded structure. Unnatural 
secondary structures such as α/β3-helices have intrinsically different CD signatures relative to 
natural analogues. Similarly, γ-residues may change the CD spectra of natural proteins. Both α→ 
γ4 and α→ γcyc substitutions destabilized the fold of GB1 by ~1.5 kcal/mol per replacement 
(Table 19). This was a surprising result for 41 as the γcyc-residues were expected to be stabilizing 
to the sheet fold. The loss of polar side-chains as in 42 only partially accounted for the observed 
difference in free energies of 41 and wild-type 1.  
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Figure 70. CD scans and thermal melts of wild-type 1 and sheet mutants 10 and 40-42 in 20 mM 
phosphate buffered water pH 7. 
 
 
Table 19. Folding Thermodynamics of Proteins 1, 10, and 40-42 from CD Measurements. 
Sequence sheet modification 
Tm  
(°C) 
ΔΔGfold vs. 1 
(kcal/mol) 
ΔΔGfold vs. 1 
(kcal/mol per 
substitution) 
1 - 81.4 ± 0.1 - - 
10 2 α→N-Me 75.6 ± 0.1 +1.0 0.5 ± 0.1 
40 4 α→ γ4 43.5 ± 0.4 +6.3 1.6 ± 0.4 
41 4 α→ γcyc 46.7 ± 0.3 +5.9 1.5 ± 0.3 
42 Point mutations 78.0 ± 0.2 +0.7 0.2 ± 0.2 
 
 
We performed simple modelling analysis of the GB1 structure focusing on the sites of 
backbone modification in 40 and 41. One explanation for the large (~5 kcal/mol) destabilization 
of the folded state was that the protein backbone is lengthened considerably from α→γ 
replacement. The central location of the γ-residues in the sheet may significantly displace key 
core residues relative to the wild-type structure. The longer sheet may be less posed to make 
crucial tertiary contacts with the central α-helix necessary to maintain the compact fold of GB1. 
 130 
To test this hypothesis, a mutant of GB1 where four α-residues, one at the end of the each strand, 
were replaced with γcyc-residues (43) was synthesized (Figures 71 and 72).  
 
 
 
Figure 71. Model based on wild-type structure (2QMT) with location of unnatural residues in 
GB1 sheet mutants 41 and 43 colored green. 
 
 
 
Figure 72. Sequences of wild-type 1 and sheet mutants 41 and 43. 
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Supporting the rationale of our design, 43 had a Tm closer to that of 1 by CD-monitored 
thermal denaturation (Figure 73). The ΔGfold of 43 was 4.9 kcal/mol more favorable than that of 
40 and 41. This large energetic difference is reasonable given the large number of tertiary 
contacts restored between the sheet and helix of GB1. On a per-residue basis, α→γcyc-substituion 
is ~1.5x more favorable towards folding if placed near the termini of the strands (Table 20). The 
slightly (~1.0 kcal/mol) destabilized fold of 43 relative to wild-type is likely due to the 
replacement of several polar and charged side-chains that may make polar contacts in the folded 
protein. 
 
 
 
Figure 73. CD scans and thermal melts of wild-type 1 and sheet mutants 41 and 43 in 20 mM 
phosphate buffered water pH 7. 
 
Table 20. Folding Thermodynamics of Proteins 1, 10, and 40-43 from CD Measurements. 
Sequence Sheet modification 
Tm  
(°C) 
ΔΔGfold vs. 1 
(kcal/mol) 
ΔΔGfold vs. 1 
(kcal/mol per 
substitution) 
1 - 81.4 ± 0.1 - - 
41 4 α→ γcyc 46.7 ± 0.3 +5.9 1.5 ± 0.3 
43 4 α→ γcyc 74.3 ± 0.2  +1.3 0.3 ± 0.1 
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4.3 CONCLUSIONS AND FUTURE DIRECTIONS 
In summary, we used a small hairpin peptide to understand and predict the thermodynamic 
impact of backbone modifications made in a larger protein system. It was observed in the sheet 
of GB1 that replacement of α-residues with N-methylated analogues was slightly destabilizing to 
the fold. We synthesized several mutants of a shorter hairpin peptide bearing N-methyl residues 
at core hydrophobic packing positions. From analyses of 2D NMR spectra, it was shown that N-
methylation is less favorable towards folding at positions closer to the β-turn. The observed 
destabilization was attributed to cis/trans amide isomerization and the diminished ability of N-
methyl residues to adopt conformations necessary for hairpin and turn formations. 
Earlier work in our lab showed that incorporation of γcyc-residues into the same hairpin 
peptide used for N-methylation studies was highly stabilizing to the sequence-encoded fold. The 
resulting mutant had a folded stability greater than that of the all α-backbone peptide. As the 
replacement of an α-residue with a γcyc-residue removes the side-chain, we synthesized 
vinylogous γ4-residues that retain the native side-chain which may be important in maintaining 
important contacts in the wild-type structure. In contrast to the cyclic analogues, γ4-residues 
destabilized the hairpin fold in the model peptide. This likely resulted from the additional 
rotatable bond present in γ4-residues relative to γcyc-residues. 
When the above strategies were applied to the larger sheet system of GB1, the results 
somewhat differed from what had been observed in the smaller model peptide. Both γ4-residues 
and γcyc-residues dramatically reduced the folded stability of GB1. Structural analysis of the 
wild-type protein suggested that insertion of γ-residues into the center of the strands of GB1 
disrupted tertiary contacts between the sheet and helix. When the positions of γcyc-substitution 
were shifted towards the termini of the strands, the resulting mutant had a folded stability within 
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1 kcal/mol of the wild-type protein. We attributed the minor energetic penalty towards folding as 
loss of polar and charged side-chains that may make contacts with other residues in the tertiary 
fold.  
The above results underscore the limitations of model systems. Although incorporation of 
γcyc-residues into the center of a short hairpin peptide was favorable, this same strategy, when 
applied to a larger protein, led to highly destabilized mutants. The sheet of GB1 has shown to a 
particularly challenging target for backbone modification, and because of this, we hypothesize 
that our sheet mimicry strategies would be applicable to more complex biological targets. Future 
challenges include the backbone modification of larger proteins or multimeric enzymes with 
interesting functions as well as exploration of unnatural resides that increase the stability of 
protein structure beyond that of natural α-amino acids. 
4.4 EXPERIMENTAL 
4.4.1 General Information 
Solvents and all other reagents were purchased from Aldrich, Baker, EMD, or Fisher and used 
without further purification. HOBt was purchased from Anaspec Inc. HCTU, NovaPEG Rink 
Amide Resin, and Fmoc-protected α-amino acids were purchased from Novabiochem. Fmoc-
protected β3-amino acids were purchased from Aapptec. Microcleavages were taken after all 
pseudoproline dipeptide couplings. Fmoc-ACC-OH was synthesized from a published route.198 
All protected Fmoc-γ4-amino acids were synthesized using published protocols.198, 201 
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4.4.2 Peptide Synthesis 
β-Hairpin peptides 33-39 were synthesized using microwave-assisted Fmoc solid-phase synthesis 
techniques on a MARS microwave reactor (CEM) using NovaPEG Rink Amide resin. Couplings 
were carried out in NMP at 70 °C for 4 min using 4 equiv. of Fmoc-protected amino acid, 4 
equiv. of HCTU, and 6 equiv. DIEA. PyAOP was used in place of HCTU for the coupling of N-
methylated residues and residues immediately following them. Deprotections were performed 
using an excess of 20% 4-methylpiperidine in DMF at 80 °C for 2 min. After each coupling or 
deprotection cycle, the resin was washed three times with DMF. Double couplings were 
performed at sequence positions following proline or N-methylated residues. Prior to cleavage, 
the resin was washed three times each with DMF, dichloromethane, and methanol, and then 
dried. Peptide cleavage was accomplished using 95% trifluoroacetic acid (TFA), 2.5% 
triisopropylsilane (TIS), and 2.5% water. Purification protocols were identical to those use for 
GB1 proteins. 
 
4.4.3 Protein Synthesis 
Proteins 40-43 were synthesized as described in Sections 2.5.2.  
4.4.4 Protein Purification and Characterization 
Proteins and peptides were purified as described in Section 2.5.3. 
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Figure 74. Analytical HPLC chromatograms of purified proteins 40-43. 
 
Table 21. MALDI-TOF MS Data for Peptides 34-39 and GB1 Mutants 40-43. 
# [M+H]
+ m/z (average) 
Calculated Observed 
34 1753.9 1753.8 
35 1753.9 1753.8 
36 1753.9 1753.7 
37 1753.9 1753.8 
38 1849.1 1849.1 
39 1791.9 1791.4 
39cyc 2037.9 2037.5 
40 6280.9 6281.8 
41 6232.1 6231.3 
42 6114.1 6114.7 
43 6204.1 6203.7 
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4.4.5 NMR Sample Preparation and Analysis 
NMR samples were prepared by dissolving peptide in 750–850 μL of degassed 50 mM 
phosphate, 9:1 H2O:D2O, pH 6.3 (uncorrected for the presence of D2O) to a final concentration 
of 0.8–3 mM. 3-(Trimethylsilyl)-1-propanesulfonic acid sodium salt (DSS, 50 mM in water) was 
added to a final concentration of 0.2 mM. Each solution was passed through a 0.2 μm syringe 
filter, and transferred to an NMR tube. The NMR tube headspace was purged with a stream of 
nitrogen prior to capping. 
NMR experiments were performed on a Bruker Avance-700 spectrometer. Chemical 
shifts are reported relative to DSS (0 ppm). TOCSY, NOESY, and COSY pulse programs used 
excitation-sculpted gradient-pulse solvent suppression. For all 2D experiments, 2048 data points 
were collected in the direct dimension and 512 data points in the indirect dimension. The mixing 
times for TOCSY and NOESY were 80 ms and 200 ms, respectively. NMR measurements were 
performed at a temperature of 278 K for hairpin peptides 33-39 and at 293 K for cyclized hairpin 
peptide 39cyc. The Sparky software package (T. D. Goddard and D. G. Kneller, SPARKY 3, 
University of California, San Francisco) was used to analyze 2D NMR data. Backbone chemical 
shift assignments for peptides 33-39 were previously reported.120, 198, 201. Analysis of NMR data 
for 33–39 and estimation of folded populations followed previously published methods.120 
Tabulated NOEs for peptide 39cyc were previously reported.198 These data were applied to 
calculate an NMR solution structure of 39cyc using the Crystallography and NMR system (CNS) 
software package according to published methods.120 
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4.4.6 Circular Dichroism 
CD spectra and thermal melts were performed and analyzed for 1 and sheet mutants 40-43 as 
described in Section 2.5.5. 
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5.0  OUTLOOK 
The above work described the development of heterogeneous-backbone oligomers with protein-
like tertiary folds. We hope that this work will enable the design of analogues of more 
biologically interesting targets, including protein-based therapeutics. Unnatural oligomers can 
offer enhanced proteolytic resistance over natural peptides.187 When designed to fold like natural 
proteins, such molecules could overcome a major drawback to peptide-based bioactive agents.202 
Before such capabilities can be fully realized, there are significant challenges that must be 
addressed. 
One limitation of protein-like foldamers is the scalability of synthesis. Many GB1 
syntheses described earlier had overall yields of less than 1% after purification. Although GB1 
contains 56 residues, a large portion of the sequence has high sheet-folding propensity, 
especially as a protected peptide on resin. This has the effect of promoting chain aggregation on 
resin which reduces yield over the 112+ steps required to synthesize the wild-type protein. This 
problem would be amplified in larger proteins of interest. One solution would be to biologically 
synthesize the desired mutants using unnatural amino acid expression techniques described in 
Chapter 1. Bacterial synthesis of proteins with significantly unnatural backbones would 
completely revolutionize the fields of peptide-based therapeutics and protein design. However, 
current technologies do not allow for several of the residue types explored in this work to be 
efficiently biologically incorporated into proteins. Furthermore, fine control over insertion of 
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multiple unnatural residues of different types is not available. Methods expanding the chemical 
backbones amenable to ribosomal protein synthesis continue to be developed.203-204 Perhaps in 
the future, recombinant synthesis of highly heterogeneous-backbone oligomers will be possible. 
Alternatively, convergent syntheses of proteins allow for the production of unnatural 
backbone oligomers with higher yields than SPPS alone. In this method, NCL, EPL, and SPPS 
can be combined to generate designer proteins with a number of modifications in a scalable 
manner.205-206 An improved version of this method using C-terminal acyl hydrazides has recently 
been applied to the synthesis of a 142 residue model protein through selective couplings between 
six peptide fragements.207 Protein prosthesis strategies highlighted in Chapter 1 could also be 
applied to targets of therapeutic interest, especially in instances where only a small portion of the 
sequence would require enhanced proteolytic resistance.  
Another challenge for foldamer research is the continued development of strategies for 
tertiary and quaternary protein structure mimicry. Because nearly all protein folds share the 
secondary structure elements present in GB1, our methods for mimicking tertiary folds on 
heterogeneous-backbone oligomers should be applicable to many other targets. The folded state 
of GB1 was tolerant of numerous backbone modifications in one sequence without 
compromising the sequence-encoded fold. This high folded stability is not representative of 
many proteins that are only marginally stable under physiological conditions. The design of 
backbone modifications that maintain or favorably change the folding free energy relative to α-
residues will expand the number of accessible biological targets and enhance our understanding 
of protein folding thermodynamics. Future work will examine the robustness of the tertiary 
structure mimicry methods developed here using other protein targets with interesting biological 
activities. 
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1H AND 13C NMR FOR SYNTHESIZED SMALL MOLECULES 30-32 
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